ምጽዓን እዩ።
x
እዚ መርበብ ሓበሬታ ኣገደስቲ ኩኪስ ይጥቀም። ብፍቓድካ ንስታቲስቲክስ ዝኸውን ናይ Google Analytics ኩኪስ ነቐምጥ።

ፖሊሲ ኩኪ ን... Slzii.com

እዚ ናይ ኩኪ ፖሊሲ ን... Slzii.com, accessible from slzii.com

What Are Cookies

As is common practice with almost all professional websites this site uses cookies, which are tiny files that are downloaded to your computer, to improve your experience. This page describes what information they gather, how we use it and why we sometimes need to store these cookies. We will also share how you can prevent these cookies from being stored however this may downgrade or 'break' certain elements of the sites functionality.

How We Use Cookies

We use cookies for a variety of reasons detailed below. Unfortunately in most cases there are no industry standard options for disabling cookies without completely disabling the functionality and features they add to this site. It is recommended that you leave on all cookies if you are not sure whether you need them or not in case they are used to provide a service that you use.

Disabling Cookies

You can prevent the setting of cookies by adjusting the settings on your browser (see your browser Help for how to do this). Be aware that disabling cookies will affect the functionality of this and many other websites that you visit. Disabling cookies will usually result in also disabling certain functionality and features of the this site. Therefore it is recommended that you do not disable cookies. This Cookies Policy was created with the help of the Cookies Policy Generator.

The Cookies We Set

  • Account related cookies

    If you create an account with us then we will use cookies for the management of the signup process and general administration. These cookies will usually be deleted when you log out however in some cases they may remain afterwards to remember your site preferences when logged out.

  • Login related cookies

    We use cookies when you are logged in so that we can remember this fact. This prevents you from having to log in every single time you visit a new page. These cookies are typically removed or cleared when you log out to ensure that you can only access restricted features and areas when logged in.

  • Site preferences cookies

    In order to provide you with a great experience on this site we provide the functionality to set your preferences for how this site runs when you use it. In order to remember your preferences we need to set cookies so that this information can be called whenever you interact with a page is affected by your preferences.

Third Party Cookies

In some special cases we also use cookies provided by trusted third parties. The following section details which third party cookies you might encounter through this site.

  • This site uses Google Analytics which is one of the most widespread and trusted analytics solution on the web for helping us to understand how you use the site and ways that we can improve your experience. These cookies may track things such as how long you spend on the site and the pages that you visit so we can continue to produce engaging content.

    For more information on Google Analytics cookies, see the official Google Analytics page.

  • Third party analytics are used to track and measure usage of this site so that we can continue to produce engaging content. These cookies may track things such as how long you spend on the site or pages you visit which helps us to understand how we can improve the site for you.

  • From time to time we test new features and make subtle changes to the way that the site is delivered. When we are still testing new features these cookies may be used to ensure that you receive a consistent experience whilst on the site whilst ensuring we understand which optimisations our users appreciate the most.

  • We also use social media buttons and/or plugins on this site that allow you to connect with your social network in various ways. For these to work the following social media sites including; {List the social networks whose features you have integrated with your site?:12}, will set cookies through our site which may be used to enhance your profile on their site or contribute to the data they hold for various purposes outlined in their respective privacy policies.

More Information

Hopefully that has clarified things for you and as was previously mentioned if there is something that you aren't sure whether you need or not it's usually safer to leave cookies enabled in case it does interact with one of the features you use on our site.

For more general information on cookies, please read the Cookies Policy article.

However if you are still looking for more information then you can contact us through one of our preferred contact methods:

  • By visiting this link: https://www.slzii.com/contact

ምድላይ (ዜና)

ሆላንድ | ቤልጅየም | ኩራሳኦ | ታይላንድ | ናይጀርያ | ጀርመን | ስጳኛ | ሜክሲኮ | ኮሎምብያ | ቬንዙዌላ | ኣርጀንቲና እዩ። | ኡራጋይ | ቺለ | ኢኳዶር | ፖርቶሪኮ | ፔሩ | ኩባ | ቦሊቭያ | ኮስታሪካ | ዶሚኒካን ሪፓብሊክ | ኤል ሳልቫዶር | ጓቲማላ | ሆንዱራስ | ኒካራጓ | ፓራጓይ | ፓናማ | ፈረንሳ | ኣይቮሪኮስት | ሞናኮ | ካሜሩን። | ሪፓብሊክ ኮንጎ | ጋቦን | ሰኔጋል | ቤኒን | ግብጺ | ሕቡራት ኢማራት ዓረብ | ቀጠር | ስዑዲ ዓረብ | ሞሮኮ | ዒራቕ | ቱኒዝያ | ሱዳን | የመን | ባሕሬን። | ኢራን | ብራዚል | ፖርቱጋል | ኣይስላንድ | ኖርወይ | ቻይና | ታይዋን | ሆንግ ኮንግ | ማካው | እስራኤል | ኔፓል | ቸክ ሪፓብሊክ | ፖላንድ | ኢጣልያ | ባንግላድሽ | ቬትናም | ቱርኪ | ማሌዥያ | ብሩነይ | ደቡብ ኮርያ | ሰሜን ኮርያ | ኢንዶነዥያ | ጃፓን | ህንዲ | ሩስያ | ፊሊፒንስ | ዩክሬን። | ስዊዘርላንድ | ፊንላንድ | ሉክሰምበርግ | ኣየርላንድ | ኢስቶንያ | ሮማንያ | ቡልጋርያ | ሕቡራት መንግስታት ኣመሪካ | ኬንያ | ቆጵሮስ | ግሪኽ | ሊክተንሽታይን። | ኡጋንዳ | ሽወደን | ዓባይ ብሪጣንያ | ኒጀር | ፓኪስታን። | ሞንጎልያ | ፍልስጤም | ኣርመንያ | ኣውስትርያ | ኣውስትራልያ | ካናዳ | ዴንማርክ | ኣልጀርያ | ጋና | ክሮኤሽያ | ሃንጋሪ | ካምቦድያ | ሲሪላንካ | ሊትዋንያ | ላቲቭያ | ማልታ | ኒውዚላንድ | ሲሸልስ | ሲንጋፖር | ስሎቫክያ | ደቡብ ኣፍሪቃ | ኣንዶራ | ዛምብያ | ሞሪሸስ | ታንዛንያ | ደሴታት ቨርጂን ብሪጣንያ | ቶጎ | ኣዘርባጃን። | ሞልዶቫ | ስሎቨንያ | ቤሊዝ | ካዛኪስታን። | ኪርጊስታን። | ሰርብያ | ኡዝቤኪስታን። | ቤላሩስ ዝበሃል ትካል | ጊኒ | ጆርጅያ | ቦዝንያን ሄርዘጎቪንን ዝበሃላ ሃገራት | ዮርዳኖስ እዩ። | ኩዌት። | ኮሶቮ | ኣልባንያ | ሞዛምቢክ | ኣፍጋኒስታን። | ታጂኪስታን። | ሞንተነግሮ | ሊብያ | ኮንጎ-ኪንሻሳ | ሊባኖስ እዩ። | ዚምባብወ | ሶርያ | ማሊ | ቡታን | ኢኳቶርያል ጊኒ | ሩዋንዳ | ማላዊ | ሚያንማር | ቦትስዋና | ሰሜን መቄዶንያ | ብሩንዲ | ጃማይካ | ኢትዮጵያ | ኒው ካሌዶንያ | ሴራሊዮን | ናሚብያ | ላኦስ | ቲሞር-ለስተ | ማልዲቭስ | ሃይቲ | ቡርኪናፋሶ | ዖማን | ባሃማስ ዝበሃላ ሃገራት | ሶማልያ | ባርባዶስ | ግሬናዳ | ፓፑዋ ኒው ጊኒ | ማልያ | ፊጂ | ሳን ማሪኖ | ፈረንሳዊት ፖሊነዥያ | ትሪኒዳድን ቶባጎን ዝበሃሉ ምሁራት ምዃኖም ይፍለጥ | ሱሪናም | ሌሶቶ | ኤርትራ | ቅድስቲ ሉቺያ | ደሴታት ካይማን | ኣንጎላ | ጋምብያ | ስዋዚላንድ | ማዳጋስካር | ላይበርያ | ሞሪታንያ | ጋያና | ቫኑዋቱ | ቻድ | ቶንጋ | ቤርሙዳ | ቱርክመኒስታን። | ሳሞኣ | ጅቡቲ | ኮሞሮስ | ከተማ ቫቲካን | ፓላው | ዶሚኒካ | ኬፕ ቨርደ | ሪፓብሊክ ማእከላይ ኣፍሪቃ | ደሴታት ሰሎሞን | ቱቫሉ | ሲንት ማርተን | ሳኦ ቶመን ፕሪንሲፐን ዝበሃሉ ምሁራት ምዃኖም ይፍለጥ | ደሴታት ቨርጂን ሕቡራት መንግስታት ኣመሪካ |
Lunit to Present Six AI Studies at AACR 2026 Highlighting Advances in Precision Oncology and Real-World Clinical Application
Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover spatial features of the tumor microenvironment not captured by conventional methods, and enable integrated analysis to better support treatment decision-making. SEOUL, South Korea , April 18, 2026 /PRNewswire/ -- Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, presented six studies at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place from April 17 to 22 in San Diego, California. Lunit at AACR 2026 The presentations highlighted Lunit's continued advancements in AI-driven biomarker development, tumor microenvironment (TME) analysis, and real-world clinical applicability. Several studies were conducted in collaboration with global partners, including Agilent Technologies. In a study conducted with Agilent Technologies and Ajou University Medical Center, researchers used Lunit SCOPE IO and uIHC to analyze over 25,000 non-small cell lung cancer (NSCLC) samples. The results showed that tumors with high c-MET expression exhibited a significant reduction in immune cell density within 30 μm of tumor cells (p<0.001), revealing a spatial immune exclusion pattern not captured by conventional analysis. These findings suggest a potential link between c-MET overexpression and immune evasion, supporting combination strategies involving MET-targeted therapy and immunotherapy. Researchers also present findings from an exploratory analysis of the phase II MOUNTAINEER trial, demonstrating that AI- quantified HER2 expression is strongly associated with treatment response in patients with HER2-positive metastatic colorectal cancer treated with tucatinib plus trastuzumab. The overall objective response rate (ORR) was 43.4%, increasing to as high as 80% in patients with higher HER2 expression, indicating a clearer dose-dependent relationship. Tumor-Infiltrating Lymphocyte (TIL) density independently predicted progression-free survival. Notably, patients with low stromal TIL levels showed no response (ORR 0%) and a significantly higher risk of disease progression. These findings highlight the increasing complexity of biomarker assessment, where both tumor characteristics and immune context need to be considered, underscoring the potential role of AI in supporting treatment decision-making. In addition to these representative studies, Lunit presented additional research abstracts at AACR 2026, further demonstrating the breadth of its AI-powered oncology research. These include studies on AI-based analysis of tumor-infiltrating lymphocyte in NSCLC in collaboration with Dr. David Rimm's lab at Yale University School of Medicine AI-based target discovery for bi-specific antibodies Biomarker research in CD47-targeted therapies "Our AACR presentations reflect how AI is increasingly translating into real-world clinical impact" said Brandon Suh, CEO of Lunit. "Across these studies, we demonstrate how AI-driven biomarkers can enhance precision, deepen our understanding of tumor biology and increasingly support treatment decision-making in clinical practice." Visit Lunit at Booth #2248 during AACR 2026 to learn more about its latest research and AI-powered solutions in cancer diagnostics and therapeutics. Lunit's featured presentations at AACR 2026 include: [Poster #0011/11] Artificial intelligence-based spatial analysis of the local tumor microenvironment in relation to c-MET expression in non-small cell lung cancer April 19, 2:00 PM - 5:00 PM, Section 1 [Poster #7735/26] HER2 expression and tumor-infiltrating lymphocytes predict response to tucatinib plus trastuzumab in HER2 -positive metastatic colorectal cancer (MOUNTAINEER): Exploratory analysis of a multicenter, Phase II trial April 22, 9:00 AM - 12:00 PM, Section 41 [Poster #4415/23] AI-powered analysis of millions of IHC images identifies 19 spatially highly co-expressed protein pairs to enable bispecific antibody development April 21, 9:00 AM - 12:00 PM, Section 11 [Poster #0080/11] Quantitative assessment of tumor-infiltrating lymphocytes using AI in non-small cell lung cancer and association with immunotherapy response April 19, 2:00 PM - 5:00 PM, Section 4 [Poster #4355/26] Cryo EM-based structural characterization of IMC-002, a next-generation anti-CD47 antibody with a unique binding site and biomarker candidates, supporting evidence of enhanced safety and efficacy April 21, 9:00 AM - 12:00 PM, Section 9 About Lunit Founded in 2013, Lunit (KRX: 328130) is a global leader on a mission to conquer cancer through AI. Our clinically validated solutions span medical imaging, breast health, and biomarker analysis—empowering earlier detection, smarter treatment decisions, and more precise outcomes across the cancer care continuum. Lunit offers a comprehensive suite spanning risk prediction and early detection to precision oncology. Our FDA-cleared Lunit INSIGHT Breast Suite and breast health solutions support cancer screening in thousands of medical institutions worldwide, while the Lunit SCOPE platform is used in research partnership with global pharma and laboratory leaders for biomarker research, and companion diagnostic development. Trusted by over 10,000 sites in more than 65 countries, Lunit combines deep medical expertise with continuously evolving datasets to deliver measurable impact—for patients, clinicians, and researchers alike. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io . About Lunit SCOPE Lunit SCOPE is a suite of AI-powered software that analyzes tissue slide images for digital pathology and AI biomarker development, aiming to optimize workflow and facilitate more accurate and predictive clinical data for clinicians and researchers. Lunit SCOPE platform offers multiple AI-powered tissue analysis products and assays that can streamline digital pathology workflow and diagnostics and enhance the drug development process. Lunit SCOPE IO analyzes the tumor microenvironment (TME) based on H&E analysis and provides AI-based predictive clinical outcome information. In addition, AI-driven Immunohistochemistry (IHC) slide analysis services are offered through products such as Lunit SCOPE PD-L1, Lunit SCOPE HER2, Lunit SCOPE ER/PR, and others.
2026-04-17 19:00:00

Yum China Announces Disclosure under Hong Kong Stock Exchange Rules in Relation to a Possible Quarterly Dividend
SHANGHAI , April 16, 2026 /PRNewswire/ -- Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987, "Yum China" or the "Company") today announced, in compliance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "HKEX") which require advance notice of board meetings at which a dividend is expected to be declared, that its board of directors (the "Board") will consider the declaration and payment of a quarterly dividend (the "Dividend"). If the Board decides to proceed, the declaration will be adopted by Board resolution on or around April 29, 2026 (Beijing/Hong Kong Time) and will be promptly disclosed by the Company. The Company makes available through the Investor Relations section of its internet website at http://ir.yumchina.com its filings with the HKEX as soon as reasonably practicable after electronically filing such materials with the HKEX. These filings may also be obtained by visiting the HKEX's website at http://www.hkex.com.hk . As no Board resolution in relation to the Dividend has been adopted as of the date of this press release, there is no assurance that the Dividend will be declared. Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. We intend all forward-looking statements to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts and by the use of forward-looking words such as "expect," "expectation," "believe," "anticipate," "may," "could," "intend," "belief," "plan," "estimate," "target," "predict," "project," "likely," "will," "continue," "should," "forecast," "outlook" or similar terminology. These statements are based on current estimates and assumptions made by us in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we believe are appropriate and reasonable under the circumstances, but there can be no assurance that such estimates and assumptions will prove to be correct. Forward-looking statements are not guarantees of performance and are inherently subject to known and unknown risks and uncertainties that are difficult to predict and could cause our actual results or events to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or assumptions will be achieved. The forward-looking statements included in this press release are only made as of the date of this press release, and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law. Numerous factors could cause our actual results or events to differ materially from those expressed or implied by forward-looking statements. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. You should consult our filings with the Securities and Exchange Commission (including the information set forth under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q) for additional detail about factors that could affect our financial and other results. About Yum China Holdings, Inc. Yum China is the largest restaurant company in China with a mission to make every life taste beautiful. The Company operates over 18,000 restaurants under six brands across around 2,500 cities in China. KFC and Pizza Hut are the leading brands in the quick-service and casual dining restaurant spaces in China, respectively. In addition, Yum China has also partnered with Lavazza to develop the Lavazza coffee concept in China. Little Sheep and Huang Ji Huang specialize in Chinese cuisine. Taco Bell offers innovative Mexican-inspired food. Yum China has a world-class, digitalized supply chain which includes an extensive network of logistics centers nationwide and an in-house supply chain management system. Its strong digital capabilities and loyalty program enable the Company to reach customers faster and serve them better. Yum China is a Fortune 500 company with the vision to be the world's most innovative pioneer in the restaurant industry. For more information, please visit http://ir.yumchina.com . Investor Relations Contact Tel: +86 21 2407 7556 E-mail: IR@yumchina.com Media Contact Tel: +86 21 2407 3824 E-mail: Media@yumchina.com
2026-04-16 09:00:00

Mabwell Establishes a Licensing and Commercialization Agreement for Denosumab Biosimilars in Malaysian Market
SHANGHAI , April 16, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has established a licensing and commercialization agreement with a strategic business partner ("the partner") in Malaysia for its Denosumab biosimilar products MAILISHU (a biosimilar of Prolia ® ) and MAIWEIJIAN (a biosimilar of Xgeva ® ) ("the products"). Under the agreement, the partner is responsible for the registration and commercialization of the products in Malaysia, while Mabwell is responsible for the development, production and commercial supply for the products. Malaysia has a population of approximately 35.97 million, with a GDP at a leading level in Southeast Asia. As a full member of PIC/S, Malaysia boasts the most mature and well-regulated pharmaceutical regulatory framework in the ASEAN region. In terms of the pharmaceutical market, Malaysia's market size stood at approximately USD 3.4 billion in 2025, maintaining a compound annual growth rate of about 6%, indicating big market potential. Mr. Huiguo Hu, Board Member, Senior Vice President and Board Secretary of Mabwell, said, "We are delighted to see that we have reached a collaboration on denosumab in another ASEAN country. Malaysia has an internationally aligned regulatory environment, strong regional recognition and significant space for development. This collaboration will further deepen Mabwell's presence in the ASEAN market. We look forward to rapidly advancing the product's local registration and commercialization with our partner's strong commercial capabilities, bring high-quality, affordable treatment options to more patients in the region." About Mabwell Mabwell (688062.SH) is an innovation-driven biopharmaceutical company with capabilities spanning the entire pharmaceutical value chain. The company is committed to providing more effective and accessible therapies to meet global medical needs, with a focus on oncology and aging-related diseases. Mabwell's mission is "Explore Life, Benefit Health" and its vision is "Innovation, from Ideas to Reality." For more information, please visit www.mabwell.com/en . Forward-Looking Statements This press release contains forward-looking statements including, but not limited to, the potential safety, efficacy, regulatory review or approval and commercial success of our product candidates and those relating to the Company's product development, clinical studies, clinical and regulatory milestones and timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. "Forward-looking statements" are statements that are not historical facts and involve a number of risks and uncertainties, which may cause actual results to be materially different from any future results expressed or implied in the forward-looking statements. These statements may be identified by the use of forward-looking expressions, including, but not limited to, "expect," "anticipate," "intend," "plan," "believe," "estimate," "potential," "predict," "project," "should," "would," and similar expressions and the negatives of those terms. Forward-looking statements are based on the Company's current expectations and assumptions. Forward-looking statements are subject to a number of risks, uncertainties, and other factors, many of which are beyond the Company's control, including, but not limited to: environment; politic; economy; society; legislation; our dependence on our product candidates, most of which are still in preclinical or various stages of clinical development; our reliance on third-party vendors, such as contract research organizations and contract manufacturing organizations; the uncertainties inherent in clinical testing; our ability to complete required clinical trials for our product candidates and obtain approval from regulatory authorities for our product candidates; our ability to protect our intellectual property; the loss of any executive officers or key personnel. In case one or more of these risks or uncertainties deteriorate, or any assumptions are incorrect, the actual results may be seriously inconsistent with the stated results. The Company cautions all the persons not to place undue reliance on any such forward-looking statements, which speaks only as of the date of this press release. The Company disclaims any obligation, except as specifically required by law and the rules of the applicable Stock authority to publicly update or revise any such statements to reflect any change in expectations or in events, conditions, or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. All forward-looking descriptions, figures and assumptions in this press release are applicable to this statement.
2026-04-16 09:00:00

Allianz Partners announces multi-year partnership with five Para athletes across the globe
Allianz Partners launches a long-term collaboration with five exceptional Para athletes as part of its "Connecting with Champions" program. The initiative reflects Allianz's commitment to inclusivity, community, and the transformative power of sports. Employees and the Allianz Partners Board Members will actively support the athletes on their journey to the LA28 Paralympic Games. PARIS and MUNICH , April 15, 2026 /PRNewswire/ -- Allianz Partners is proud to announce a multi-year partnership with five Para athletes from four different countries: Bailey Moody , a wheelchair basketball player from the USA. She won one Silver medal at the Paris 2024 Paralympic Games and one Bronze medal in the Tokyo 2020 Paralympic Games. Jaydin Blackwell , a Para track & field athlete from the USA. He won two Gold medals at the Paris 2024 Paralympic Games and was selected 2025 USA Track & Field Men ́s Para athlete of the Year . Jamieson Leeson , a wheelchair boccia player from Australia. She won one Silver medal at the Paris 2024 Paralympic Games. Josia Topf , a para swimmer from Germany. He won one Gold, one Silver and one Bronze medal at the Paris 2024 Paralympic Games and was selected Para athlete of the year 2025 in Germany . Ksénia Chasteau , a wheelchair tennis player from France and ranked #7 in the International Tennis Federation (ITF) Singles World Ranking. These remarkable individuals were chosen following a global employee voting process in 2025, which engaged Allianz Partners employees worldwide in selecting athletes who embody resilience, determination, and excellence. Tomas Kunzmann, Chief Executive Officer of Allianz Partners, states: "At Allianz Partners, we believe in the power of sports to unite and inspire. We are proud to support these five exceptional Para athletes as their authenticity, resilience and excellence in execution mirror our culture and ambitions. Together, we believe in the strength of community and our aim is to support the athletes' journeys while fostering meaningful connections between our employees, partners, customers, and the athletes themselves." Jean-Marc Pailhol, Connecting with Champions program sponsor , adds: "We are committed to providing the athletes with comprehensive support from the Allianz Partners community, which includes its employees and Board Members. Our ambition is that this program raises awareness for our athletes and creates a unique connection between the Allianz family and these inspiring champions. We look forward to seeing them succeed at the LA28 Games." Chris McHugh, Chief Executive Officer of Allianz Partners Australia, says: "Para athletes embody focus, discipline, and resilience - qualities that deeply resonate with us at Allianz Partners Australia. These traits reflect the way our teams strive to support customers during critical moments, often when things don't go as planned. It's this shared commitment to perseverance and excellence that makes us proud to be part of this campaign." This collaboration builds on Allianz's long-standing partnership with the Paralympic Movement, which celebrates its 20th year anniversary in 2026. This initial engagement led to a strategic relationship, evolving to Allianz becoming Worldwide Olympic & Paralympic Partner in 2021, which will continue through 2032. As the Official Insurer of the LA28 Paralympic Games, Allianz is dedicated to empowering athletes and fans worldwide, transcending social and cultural barriers through the unifying power of sports. Stay tuned for more updates on the "Connecting with Champions" program and the incredible journeys of these five Para athletes via the Allianz Partners Social Media channels. About Allianz Partners Allianz Partners is a world leader in B2B2C insurance and assistance, offering global solutions that span international health and life, travel insurance, mobility and assistance. Customer driven, our innovative experts are redefining insurance services by delivering future-ready, high-tech high-touch products and solutions that go beyond traditional insurance. Our products are embedded seamlessly into our partners' businesses, sold through intermediary channels or directly to customers through the Allianz brand. Present in over 73 markets, our 22,600 employees speak 70 languages, handle over 95 million cases each year, and are motivated to go the extra mile to offer peace of mind to our customers around the world. For more information, please visit: http://www.allianz-partners.com Social media Follow us on X @AllianzPartners Follow us on LinkedIn Allianz Partners Follow us on Youtube /allianzpartners Follow us on Instagram @allianzpartners
2026-04-14 23:00:00

Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
MELBOURNE, Australia and INDIANAPOLIS , April 15, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed with TLX101-Tx (131I-iodofalan) in Telix's pivotal IPAX BrIGHT trial [1] , marking the first radiopharmaceutical therapy to enter Phase 3 development for glioblastoma, an aggressive form of brain cancer. The patient was dosed at Austin Health in Melbourne, Australia, under the supervision of Professor Hui Gan. IPAX BrIGHT is assessing the safety and efficacy of TLX101-Tx in combination with chemotherapy (lomustine), compared to chemotherapy alone. The global, multicenter, open-label study will enroll patients with radiographically confirmed recurrent glioblastoma at first recurrence. Telix's commitment to advancing care for patients with glioblastoma is driven by the significant unmet need in this space. In the past 25 years, only two drugs have been approved by the United States Food and Drug Administration (FDA) for glioblastoma [2] , and no standard treatment currently exists for recurrent disease. Patients therefore face limited treatment options after initial therapy. TLX101-Tx offers a novel approach by targeting the L-type amino acid transporter 1 (LAT1), a transporter that enables the radiopharmaceutical to cross the blood-brain barrier and delivers therapy directly to the tumor. IPAX BrIGHT expands upon promising data from earlier trials in the recurrent glioblastoma setting, including IPAX-1 [3] , which reported a median overall survival (OS) of 13 months from the initiation of treatment with TLX101-Tx, or 23 months from initial diagnosis [4] . Preliminary results from the IPAX-Linz investigator-initiated trial of TLX101-Tx were consistent and confirmatory to IPAX-1, with a median OS of 12.4 months from initiation of treatment and 32.2 months from initial diagnosis [5] . Beyond the clinical trial setting, an early access program for TLX101-Tx in Europe has dosed 18 patients at first recurrence or later, further establishing the clinical utility of TLX101-Tx. Professor Gan, Director of Cancer Clinical Trials at Austin Health, said, "Based on the prior safety profile and early efficacy data for TLX101-Tx in the IPAX-1 and IPAX-Linz studies, I am pleased to continue to explore this therapeutic modality in the first radiopharmaceutical pivotal trial in recurrent glioblastoma, where there are currently few effective treatment options." Dr. David N. Cade, Group Chief Medical Officer, Telix, added, "Through the IPAX BrIGHT trial, we aim to offer a new option for patients affected by glioblastoma. This registration-enabling study represents a major step forward in our mission to improve therapeutic options in neuro-oncology. With very limited innovation in treatment in recent decades, TLX101-Tx has the potential to become a first-in-class therapy that meaningfully improves patient outcomes." The IPAX BrIGHT study has received regulatory approval in Australia, Austria, Belgium and the Netherlands with approval being sought in additional jurisdictions. Telix's investigational PET [6] imaging agent for glioma, TLX101-Px (floretyrosine F 18) will be used for patient selection in IPAX BrIGHT, as well as assessing metabolic tumor response according to PET RANO 1.0 [7] . About TLX101-Tx TLX101-Tx ( 131 I-iodofalan) is a systemically administered radiopharmaceutical therapy that targets L-type amino acid transporter 1 (LAT1), which is typically over-expressed in glioblastoma. TLX101-Tx utilizes a small molecule approach due to the need to cross the blood brain barrier, the normal protective barrier that prevents many potential drug candidates entering the brain. In addition to the IPAX-1 and IPAX-Linz studies, TLX101-Tx is also under investigation in the IPAX-2 Phase 1 study in combination with post-surgical standard of care treatment in patients with newly diagnosed glioblastoma [8] . TLX101-Tx has received orphan drug designation in the U.S. and Europe for the treatment of glioma. TLX101-Tx and TLX101-Px have not received a marketing authorization in any jurisdiction. About glioblastoma Glioblastoma (GBM), is a high-grade glioma and the most common and aggressive form of primary brain cancer, with approximately 22,000 new cases diagnosed annually in the U.S. [9] . The mainstay of treatment for GBM comprises surgical resection, followed by combined radiotherapy and chemotherapy. Despite such treatment, recurrence occurs in almost all patients [10] , with an expected survival duration of 12-15 months from diagnosis [11] . About Telix Pharmaceuticals Limited Telix is a global biopharmaceutical company focused on the development and commercialization of radiopharmaceuticals with the goal of addressing significant unmet medical need in oncology and rare diseases. Telix is headquartered in Melbourne (Australia) with international operations in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland) and Japan. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX). Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn , X and Facebook . Telix Investor Relations (Global) Ms. Kyahn Williamson SVP Investor Relations and Corporate Communications kyahn.williamson@telixpharma.com Telix Investor Relations (U.S.) Ms. Annie Kasparian Director Investor Relations and Corporate Communications annie.kasparian@telixpharma.com Telix Investor Relations (Australia) Ms. Charlene Jaw Associate Director Investor Relations charlene.jaw@telixpharma.com Media Contact Eliza Schleifstein 917.763.8106 (Mobile) Eliza@schleifsteinpr.com Legal Notices Cautionary Statement Regarding Forward-Looking Statements. You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website. The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement. This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as "may", "expect", "intend", "plan", "estimate", "anticipate", "believe", "outlook", "forecast" and "guidance", or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix's good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix's business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix's business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix's preclinical and clinical trials, and Telix's research and development programs; Telix's ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix's product candidates, including TLX101-Px and TLX250-Px, manufacturing activities and product marketing activities; Telix's sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix's product candidates, if or when they have been approved; Telix's ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix's expenses, future revenues and capital requirements; Telix's financial performance; developments relating to Telix's competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix's business, including as a result of war or other geopolitical conflicts; and the pricing and reimbursement of Telix's product candidates, if and after they have been approved. Telix's actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements. Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or TM symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties. ©2026 Telix Pharmaceuticals Limited. All rights reserved. [1] ClinicalTrials.gov ID: NCT07100730 . [2] Temozolomide approved in 2005 and Bevacizumab in 2009. [3] ClinicalTrials.gov ID: NCT03849105 . [4] Pichler et al. Neurooncol Adv. 2024. https://doi.org/10.1093/noajnl/vdae130 [5] Telix ASX disclosure April 16, 2025. Date presented by Professor Josef Pichler at the Nuclear Medicine and Neurooncology (NMN) Symposium in Vienna (Austria), May 2025. [6] Positron emission tomography. [7] Response Assessment in Neurooncology practice guidelines for the clinical use of PET imaging in gliomas. [8] ClinicalTrials.gov ID: NCT05450744 . [9] Ostrom 2022, CBTRUS (Central Brain Tumor Registry of the United States) Statistical Report. [10] Park et al. Journal of Clinical Oncology. 2010. [11] Ostrom et al. Neuro Oncol. 2018.
2026-04-14 22:50:00

"Атлетико" вышел в 1/2 финала ЛЧ, несмотря на поражение от "Барселоны"
Футболисты "Атлетико" со счетом 1:2 проиграли "Барселоне" в ответном матче четвертьфинальной стадии Лиги чемпионов. Встреча прошла на стадионе "Метрополитано" в Мадриде. Как передает Vesti.az со ссылкой на ТАСС, в составе "Барселоны" голы забили Ламин Ямаль (4-я минута) и Ферран Торрес (24). У проигравших отличился Адемола Лукман (31). На 80-й минуте после вмешательства видеоассистентов рефери с поля за лишение явной возможности забить гол был удален защитник "Барселоны" Эрик Гарсия. Первая игра между соперниками завершилась победой "Атлетико" на чужом поле со счетом 2:0. В той игре каталонская команда с 44-й минуты играла в меньшинстве из-за удаления защитника Пау Кубарси. Следующим соперником "Атлетико" станет сильнейший из противостояния между английским "Арсеналом" и португальским "Спортингом". В первой встрече лондонцы одержали минимальную победу в гостях (1:0). Ответная встреча пройдет в столице Великобритании 15 апреля.
2026-04-14 22:37:01

Telix Successfully Prices and Upsizes US$600 Million Convertible Bonds
MELBOURNE, Australia and Indianapolis , April 15, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) (" Telix ") is pleased to announce that it has successfully priced and upsized its 1.50 per cent convertible notes due 2031 to be issued by its wholly-owned subsidiary, Telix Pharmaceuticals (Investments) Inc. (the " Issuer "), and guaranteed by Telix and Telix Pharmaceuticals (US) Inc. from US$550 million to US$600 million due to strong demand (the " Offering "). The convertible notes, also referred to as "convertible bonds" (" Convertible Bonds "), are convertible into fully paid ordinary shares in Telix (" Ordinary Shares "). The Offering received strong support from eligible investors globally. The initial conversion price of the Convertible Bonds is US$13.85 (~A$19.55) per Ordinary Share, which represents a conversion premium of 37.5 per cent over the reference share price (A$14.22 per Ordinary Share), subject to anti-dilution adjustments set out in the final terms and conditions of the Convertible Bonds. The Convertible Bonds will bear interest at a rate of 1.50 per cent per annum. Interest will be payable quarterly in arrear on 22 January, 22 April, 22 July and 22 October in each year, beginning on 22 July 2026. The Convertible Bonds will mature on or about 22 April 2031, unless redeemed, repurchased, or converted in accordance with their terms. Under the reverse bookbuilding process announced by Telix on 14 April 2026 (the " Concurrent Repurchase "), Telix will concurrently repurchase approximately A$637 million of its existing A$650 million convertible bonds due 2029 (" Existing Convertible Bonds "). The Concurrent Repurchase will result in the repurchase and cancellation of more than 85% of the Existing Convertible Bonds. Telix intends to exercise its right to redeem the remaining Existing Convertible Bonds. Settlement of the Offering and the Concurrent Repurchase is expected on 22 April 2026 and is subject to satisfaction of customary conditions. The Existing Convertible Bonds that are to be repurchased will be cancelled in accordance with their terms and conditions. Managing Director and Group CEO, Dr. Christian Behrenbruch, said: "The successful completion of the convertible bonds refinance is in line with our capital management strategy and provides financial flexibility for Telix. We are pleased with the support we have received from both existing and new investors as part of the concurrent repurchase and new issue of convertible bonds." J.P. Morgan Securities plc (" J.P. Morgan ") is Sole Bookrunner on the Offering and Sole Dealer Manager on the Concurrent Repurchase. J.P. Morgan completed the delta placement of Ordinary Shares at a clearing price of A$14.22 per Ordinary Share, which represents an 8.0 per cent discount to Telix's closing price of A$15.45 on 14 April 2026 and a 3.2 per cent discount to the 5-day volume weighted average price per share of A$14.69. This acts as the reference price to determine the initial conversion price of the Convertible Bonds. Key terms of the Convertible Bonds Issuer Telix Pharmaceuticals (Investments) Inc. Guarantors Telix Pharmaceuticals Limited and Telix Pharmaceuticals (US) Inc. Issue Size US$600 million Ranking Direct, unconditional, unsubordinated and unsecured obligations of the Issuer and Guarantors Maturity Date On or about 22 April 2031 (5 years) Investor Put Option At the end of year 3 Coupon / Yield 1.50% p.a. Conversion Premium 37.5% above the Reference Share Price Reference Share Price A$14.22 per Ordinary Share Conversion Price Adjustment Standard anti-dilutive adjustments including conversion price adjustment for all dividends paid by Telix Stock Borrow Facility Elk River Holdings Pty Ltd as the trustee for The Behrenbruch Family Trust (" Stock Lender ") in which Dr Behrenbruch holds an indirect interest has entered into a stock lending agreement with an affiliate of J.P. Morgan (" Stock Borrower ") over 15 million Ordinary Shares. The Stock Borrow Facility has a term of 11 months. Listing SGX-ST Selling Restrictions Reg S (Cat 2) only About Telix Pharmaceuticals Limited Telix is a global biopharmaceutical company focused on the development and commercialization of radiopharmaceuticals with the goal of addressing significant unmet medical need in oncology and rare diseases. Telix is headquartered in Melbourne (Australia) with international operations in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland) and Japan. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX). Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn , X and Facebook . This announcement has been authorized for release by the Telix Pharmaceuticals Limited Board of Directors. Legal Notices Cautionary Statement Regarding Forward-Looking Statements. You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website. The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including Australia, Singapore, and the United States. The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement. This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as "may", "expect", "intend", "plan", "estimate", "anticipate", "believe", "outlook", "forecast" and "guidance", or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix's good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix's business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix's business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix's preclinical and clinical trials, and Telix's research and development programs; Telix's ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix's product candidates, including TLX101-Px and TLX250-Px, manufacturing activities and product marketing activities; Telix's sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix's product candidates, if or when they have been approved; Telix's ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix's expenses, future revenues and capital requirements; Telix's financial performance; developments relating to Telix's competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix's business, including as a result of war or other geopolitical conflicts ; and the pricing and reimbursement of Telix's product candidates, if and after they have been approved. Telix's actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements. Neither this announcement nor any copy hereof may be taken into or distributed in the United States. The information contained in this announcement is not for distribution, directly or indirectly, in or into the United States. The Convertible Bonds, the guarantees and the Ordinary Shares to be issued upon conversion of the Convertible Bonds have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the " Securities Act ") or the securities laws of any state or other jurisdiction of the United States and they may not be offered or sold, resold, transferred or delivered, directly or indirectly, within the United States or to, or for the account or benefit of U.S. persons (as defined in Regulation S under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state or local securities laws. The Convertible Bonds and the guarantees are being offered and sold solely outside the United States in an "offshore transaction" as defined in, and in reliance on Regulation S under the Securities Act. Nothing in this announcement or anything attached to it shall form the basis of any contract or commitment. The Concurrent Repurchase is not being made and will not be made, directly or indirectly, in or into the United States. This includes, but is not limited to, facsimile transmission, electronic mail, telex, telephone, the internet and other forms of electronic communication. The Existing Convertible Bonds may not be tendered in the Concurrent Repurchase by any such use, means, instrumentality or facility from or within the United States or by persons located or resident in the United States as defined in Regulation S of the Securities Act. Any purported tender of Existing Convertible Bonds made by a person located in the United States will not be accepted. This communication may not be distributed to the press or other media or forwarded, photocopied, passed on or, in any other manner, transmitted to any other person. Non-compliance with the foregoing may constitute a violation of law. This information is subject to change. This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or TM symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties. ©2026 Telix Pharmaceuticals Limited. All rights reserved.
2026-04-14 22:35:00

США пригрозили санкциями банкам КНР, ОАЭ и Омана за ведение дел с Ираном
Соединенные Штаты угрожают введением санкций в отношении некоторых банков Китая и его специального административного района Гонконг, Объединенных Арабских Эмиратов (ОАЭ) и Омана, которые, предположительно, поддерживают деловые связи с Ираном. Как передает Vesti.az со ссылкой на ТАСС, об этом сообщило со ссылкой на письмо Госдепартамента агентство Associated Press. По его данным, в документе, разосланном в финансовые учреждения упомянутых стран, содержится предупреждение о рисках ведения дел с исламской республикой и возможности введения вторичных санкций. По утверждению американского внешнеполитического ведомства, Иран в 2024 году провел по меньшей мере $9 млрд через корреспондентские счета в США, используя подставные фирмы, в основном базирующиеся в Гонконге и ОАЭ.
2026-04-14 22:30:31

Азербайджан не дотягивает до квоты OPEC+: ОТЧЕТ
В марте 2026 года среднесуточная добыча сырой нефти в Азербайджане составила 457 тыс. баррелей. Как передает Vesti.az, об этом сообщает «APA-Economics» со ссылкой на ежемесячный отчет OPEC. В феврале этот показатель составлял 458 тыс. баррелей в сутки. По данным отчета, в первом квартале текущего года среднесуточная добыча нефти в стране также находилась на уровне 457 тыс. баррелей, что на 9 тыс. баррелей меньше по сравнению с аналогичным периодом прошлого года (466 тыс. баррелей). Отмечается, что по итогам 2025 года среднесуточная добыча нефти в Азербайджане составила 461 тыс. баррелей, что на 20 тыс. баррелей ниже показателя 2024 года. Согласно договоренностям в рамках соглашения «OPEC+», квота Азербайджана по добыче нефти до конца 2026 года составляет 551 тыс. баррелей в сутки. Таким образом, в марте и в первом квартале страна добывала на 94 тыс. баррелей меньше установленного лимита.
2026-04-13 12:38:05

MAXHUB Expands into Latin America with First Mexico City Experience Center
Global leader in collaborative display solutions plants roots in Mexico, launches partner program for local integrators MEXICO CITY , April 13, 2026 /PRNewswire/ -- MAXHUB, the world's leading provider of integrated commercial display and unified communications, has opened its first Latin American Experience Center in Mexico City's Polanco district, marking a significant expansion of its global footprint into one of the world's fastest-growing economic regions. Ribbon-Cutting Ceremony for the Grand Opening of MAXHUB Mexico Experience Center The facility, themed "Bienvenidos al Hogar de Innovación — Welcome to the Home of Innovation," represents MAXHUB's commitment to establishing a genuine local presence rather than remote sales operations. The company, which holds the number-one position globally in interactive flat-panel displays, currently serves customers in over 140 countries across the corporate, education, healthcare, and government sectors. "Mexico is not just a market for us — it's a mindset," said Aaron Xiao, President of MAXHUB's Overseas Business Unit, speaking at the opening ceremony on April 8. "A mindset of building bridges, not walls. Our opening here today isn't about planting a flag. It's about planting roots." Three Pillars of Presence MAXHUB's approach to the Mexican market is built on three pillars that distinguish it from typical market entries: Localization : Building a team of Mexican professionals who understand local business culture, with Spanish-language technical support as a standard offering Innovation : Providing immersive, hands-on experiences across six distinct environments — from huddle rooms to executive boardrooms — where businesses can test solutions before committing Partnership : Launching the LATAM Collaboration Partner Program, which shares internal sales leads with certified local integrators rather than keeping direct relationships exclusive "Most vendor programs are one-way: we give you products, you find customers," explained Linda, Regional Director for Latin America. "We're making it two-way. When a multinational approaches MAXHUB directly, we bring in our certified local partners as the implementation team. They get the revenue. We get the confidence that the customer will be served properly." A Destination, Not a Showroom The 7th-floor Experience Center in Polanco is designed as a working laboratory where businesses can experience collaboration solutions in context. Visitors can walk through environments purpose-built for different use cases — impromptu team meetings, formal presentations, hybrid learning, and creative brainstorming — then work with local engineers to customize implementations. "This isn't a sales office," Linda emphasized. "It's a destination where partners can see, touch, and experience the future of collaboration. Then we help install it, train their people, and support it — all with engineers who speak their language and understand their challenges." Strategic Timing The opening highlights Mexico as a bridge in North-South American business. As hybrid work becomes permanent, demand for collaboration technology is growing across Latin America. Aaron notes, "Everyone talks about nearshoring," but effective cross-border collaboration is essential, "and that's what we're here to fill." About the Opening Event The grand opening on April 8 brought together industry leaders, technology partners, and media representatives for a day-long program that included an industry roundtable featuring executives from MAXHUB, Biamp, Kramer, and Steelcase; product demonstrations across six experience zones; and the formal launch of the LATAM Collaboration Partner Program with initial contract signings. About MAXHUB MAXHUB is the world's No.1 in both collaboration boards and all-in-one LED displays (According to Futuresource and TrendForce). The company serves customers in over 140 countries across corporate, education, healthcare, and government sectors. Founded in 2017, MAXHUB was named to the Forbes China Globalization Leaders TOP 30 list in 2024-2025. For more information about MAXHUB and the LATAM Collaboration Partner Program, visit www.maxh ub.com .
2026-04-13 12:36:00

“Meta”nın ən güclü süni intellekt modeli
“Meta” şirkəti bu günə qədər hazırladığı ən güclü süni intellekt modeli olan “Muse Spark”ı təqdim edib. Model xüsusi olaraq “Meta” məhsulları üçün hazırlanıb. “Meta Superintelligence Labs” (MSL) tərəfindən doqquz ay davam edən intensiv inkişaf prosesindən sonra təqdim edilən “Muse Spark” “Muse” seriyasının ilk nəsli kimi kompakt və sürətli işləmə xüsusiyyətlərinə malikdir. Model elm, riyaziyyat və səhiyyə sahələrində mürəkkəb problemləri məntiqi şəkildə həll etmək üçün optimallaşdırılıb. Yenilənmiş “Meta AI” tətbiqi və veb versiyası artıq daha sürətli cavablar təqdim edir və mürəkkəb tapşırıqları yerinə yetirə bilir. İstifadəçilər müxtəlif rejimlər arasında keçid edərək paralel şəkildə çalışan bir neçə agentdən istifadə edə bilərlər. Məsələn, səyahət planlaşdırılarkən bir agent marşrutu qurur, digəri məkanları müqayisə edir, üçüncüsü isə fəaliyyətlər təklif edir. “Muse Spark”ın çoxmodal imkanları sayəsində sistem yalnız mətni deyil, vizual məlumatları da analiz edə bilir. “Meta”dan bildirilib ki, səhiyyə ilə bağlı funksiyalar mütəxəssislərlə əməkdaşlıq çərçivəsində hazırlanıb və istifadəçilərə daha etibarlı məlumat təqdim etməyə yönəlib. Model, həmçinin vizual kodlaşdırma sahəsində də imkanlar təqdim edir. İstifadəçilər sadə sorğularla interaktiv panellər, retro oyunlar və ya mini simulyatorlar yarada bilirlər. Ülkər XASPOLADOVA, “Azərbaycan”
2026-04-10 14:49:10

ADY Orta dəhlizdə tranzit imkanlarını genişləndirmək üçün strateji tədbirlər görür
Bu günlər Dünya Bankının təşkilatçılığı ilə Avstriyanın paytaxtı Vyana şəhərində Regional Dəmir Yolu Seminarı keçirilib. Seminar çərçivəsində baş tutan “Ölkələrin baxışı: Mövcud geosiyasi şəraitdə dəmir yolları üçün perspektivlər və çağırışlar” sessiyasında çıxış edən AZCON Holding şirkətlərindən olan “Azərbaycan Dəmir Yolları” QSC-nin (ADY) sədr müavini Arif Ağayev Azərbaycanın regional nəqliyyat bağlantılarındakı mövqeyi, Orta Dəhlizin artan potensialı, icrası davam edən iri yerli layihələr və mövcud geosiyasi vəziyyət fonunda ADY-nin strateji baxışı barədə məlumat verib. O bildirib ki, Azərbaycan Şərq–Qərb və Şimal–Cənub nəqliyyat dəhlizlərinin kəsişməsində yerləşərək Avrasiyanın mühüm tranzit qovşağı rolunu gücləndirir. Dayanıqlı Orta dəhliz üçün daha güclü regional əlaqələndirmə vacibdir. Müasir geosiyasi şəraitdə bağlantıların koordinasiyalı, dayanıqlı və rəqəmsal təşkili məqsədilə Trans-Xəzər Beynəlxalq Nəqliyyat Marşrutu və “Avrasiya Nəqliyyat Marşrutu” Beynəlxalq Assosiasiyası çərçivəsində əməkdaşlıq genişləndirilib, Qazaxıstan və Çinlə elektron sənəd mübadiləsi və məlumat inteqrasiyası sürətləndirilib. ADY son illərdə Orta dəhlizin Azərbaycandan keçən hissəsində tranzit ötürücülüyünü artırmaq üçün əsaslı işlər görüb. Xüsusilə rəqəmsal həllər tətbiq olunub və tranzit müddətləri azaldılıb. Nəticədə, 2025-ci ildə Şərq–Qərb istiqamətində 392 blok-qatar qəbul edilib ki, bu da 2024-cü ilin göstəricisini 37 faiz üstələyir. Eyni zamanda, 2025-ci ildə Bakı Limanında konteyner dövriyyəsi rekord səviyyəyə çataraq 100 min TEU-ni keçib. Bundan əlavə, dəhlizlər üzrə ötürücülük qabiliyyətinin artırılması, Bakı Limanının illik yükaşırma həcminin 260 min TEU-ya qədər genişləndirilməsi və sərhəd-keçid prosedurlarının təkmilləşdirilməsi istiqamətində işlər davam etdirilir. Züleyxa ƏLİYEVA, “Azərbaycan”
2026-04-10 14:49:10

Odessanın yaşayış məntəqələrinə hücumlar insan tələfatı ilə nəticələnib
Aprelin 6-da gecə saatlarında Rusiya ordusu Ukraynanın Odessa şəhərində mülki obyektləri kütləvi atəşə tutub, xüsusilə yaşayış binalarını hədəf alıb. AZƏRTAC bu barədə Odessa Şəhər Hərbi Administrasiyasının rəhbəri Sergey Lısakın açıqlamasına istinadla xəbər verir. Səhər saatlarına olan məlumata görə, üç ölüm hadisəsi rəsmi olaraq təsdiqlənib. Ən böyük itki Rusiyanın zərbəsi nəticəsində bir uşağın həyatını itirməsi olub. Yaralılara gəldikdə, onların sayı 10-a çatıb. Onlardan ikisinin vəziyyəti ağırdır: bir xəstə neyrocərrahiyyə, digəri isə yanıq reanimasiya şöbəsinə yerləşdirilib. Odessanın tibb işçiləri gücləndirilmiş iş rejimində çalışırlar. On nəfər yaralı arasında 2 yaşında uşaq və 17 və 18 yaşlı iki yeniyetmə var. Xoşbəxtlikdən, onların həyatı təhlükə altında deyil. Rusiya ordusu Odessanın iki əsas ərazisində mülki infrastruktura hücum edib. Primorski rayonunda çoxmərtəbəli yaşayış kompleksinə və yeddi fərdi evə ziyan dəyib. Kommunal xidmətlər artıq ərazini təmizləyir. Kiyev rayonunda isə bir çoxmərtəbəli binaya və beş fərdi evə ziyan dəyib. Ümumilikdə, özəl uşaq bağçası, bir mağaza və bütöv bir dayanacaq zərbə alıb, 27 avtomobilə ziyan dəyib. Təcili yardım qrupları hücumdan zərər çəkən ərazilərə yerləşdirilib. Kommunal xidmət işçiləri və xilasedicilər ziyanı mümkün qədər tez aradan qaldırmaq üçün çiyin-çiyinə çalışırlar.
2026-04-06 07:47:53

Dogness Reports Financial Results for the Six Months Ended December 31, 2025
DONGGUAN, China and PLANO, Texas , April 2, 2026 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced its financial results for the six months ended December 31, 2025. Mr. Silong Chen, Chief Executive Officer of the Company, commented: "The first half of fiscal 2026 presented challenges as U.S. tariff policies temporarily impacted our overall revenue and margins. Despite these headwinds, our core traditional pet products category demonstrated strong resilience, growing 14.6% year-over-year driven by increased global demand and loyal customer orders." "To mitigate external pressures, we took proactive steps to optimize operations, successfully reduced our general and administrative expenses by over 20%. At the same time, we strategically invested in targeted marketing to expand our brand footprint and capture future market share." "Looking ahead, our outlook remains highly optimistic. We are accelerating our R&D initiatives to introduce a new generation of intelligent, eco-friendly pet products that meet evolving consumer demands. Backed by a robust portfolio of over 200 patents and a fully integrated supply chain, Dogness is well-positioned to navigate these temporary trade fluctuations, return to sustainable growth, and deliver long-term shareholder value." Financial Results for the Half Year Ended December 31, 2025 Revenue decreased by approximately $4.4 million, or 36.2%, from about $12.1 million for the six months ended December 31, 2024 to approximately $7.7 million for the six months ended December 31, 2025. The decrease in revenue was primarily attributable to the impact of United State's tariff policies. The following table breaks down Dogness' revenue by product and service type for the six months ended December 31, 2025 and 2024: For the six months ended December 31, 2025 2024 Products and services category Revenue Revenue Variance % Products Traditional pet products $ 5,343,190 $ 4,660,824 14.6 % Intelligent pet 1,701,321 4,546,642 (62.6) % Climbing hooks and others 666,390 2,878,245 (76.8) % Total revenue from products 7,710,901 12,085,711 (36.2) % ─ Traditional pet products Revenue from traditional pet products increased by approximately $0.7 million, or 14.6%, from approximately $4.7 million for the six months ended December 31, 2024 to approximately $5.3 million for the six months ended December 31, 2025. The increase was mainly driven by increased sales volume for the six months ended December 31, 2025. Among the total revenue increase, $0.5 million was from sales to customers in international markets, and $0.2 million was from sales to customers in China domestic market, primarily due to increased orders from our current customers. ─ Intelligent pet products Revenue from intelligent pet products decreased by approximately $2.8 million, or 62.6%, from around $4.5 million for the six months ended December 31, 2024, to roughly $1.7 million for the same period in 2025. The decrease was mainly driven by a decrease in sales volume and average selling price for the six months ended December 31, 2025, compared to the six months ended December 31, 2024. Among the total revenue decrease, $1.4 million decrease was from sales to customers in international markets and $1.5 million was from sales to customers in China domestic market, primarily due to decreased orders from our current customers. ─ Climbing hooks and others Revenue from climbing hooks and other products decreased by about $2.2 million, or 76.8%, from roughly $2.9 million for the six months ended December 31, 2024, to about $0.7 million for the same period in 2025. The decrease was mainly driven by decreased sales volume and average selling price during the six months ended December 31, 2025, compared to the six months ended December 31, 2024. Among the total revenue decrease, $1.5 million decrease was from sales to customers in international markets and $0.7 million was from sales to customers in China domestic market, primarily due to the decreased orders from our current customers. ─ International vs. Domestic sales Total international sales decreased by about $2.4 million, or 29.8%, from approximately $8.0 million for the six months ended December 31, 2024, to about $5.6 million during the same period in 2025, driven by significant decrease in sales orders, due to the impact of United States's tariff policies. Domestic sales decreased by approximately $2.0 million, or 48.8%, from about $4.1 million for the six months ended December 31, 2024 to about $2.1 million for the six months ended December 31, 2025. The decrease in our domestic market sales was driven by significant decreased sales orders from our main customers, who are also affected by United States's tariff policies, resulting in reduced demand for our products. Cost of revenues decreased by $1.8 million, or 21.0%, from approximately $8.7 million for the six months ended December 31, 2024, to approximately $6.8 million for the six months ended December 31, 2025, due to a significant decrease in sales volume. As a percentage of revenues, the cost of goods sold increased by 17.1 percentage points to 88.8% for the six months ended December 31, 2025, compared to 71.7% for the six months ended December 31, 2024. Gross profit decreased by approximately $2.6 million, or 74.6%, from about $3.4 million for the six months ended December 31, 2024 to about $0.9 million for the six months ended December 31, 2025, primarily attributable to lower sales volume and reduced average selling price for intelligent pet products and climbing hooks and others products. Gross profit margin decreased to 11.2% for the six months ended December 31, 2025 from 28.3% for the six months ended December 31, 2024. Total operating expenses increased by approximately $0.7 million or 13.0%, to about $6.3 million for the six months ended December 31, 2025, compared to around $5.6 million for the same period in 2024. ─ Selling expenses Selling expenses increased by about $0.6 million, or 97.7%, from approximately $0.6 million for the six months ended December 31, 2024, to approximately $1.2 million for the six months ended December 31, 2025. The increase was primarily attributable to the increase in entertainment fees and advertising fees for the six months ended December 31, 2025. Selling expenses were 16.0% and 5.2% of total revenue for the six months ended December 31, 2025, and 2024, respectively. ─ General and Administrative Expenses General and administrative expenses decreased by approximately $0.9 million, or 20.3%, from about $4.3 million for the six months ended December 31, 2024, to roughly $3.4 million for the same period in 2025. The decrease was primarily due to the reduction in office renovation expenses, depreciation expenses and share-based compensation expenses. As a percentage of sales, general and administrative expenses were 44.6% and 35.7% of total revenue for the six months ended December 31, 2025 and 2024, respectively. ─ Research and Development Expenses Research and development expenses decreased by $0.1 million, or 19.8%, from approximately $0.7 million for the six months ended December 31, 2024, to about $0.5 million for the same period in 2025. As a percentage of sales, research and development expenses were 6.9% and 5.5% of total revenue for the six months ended December 31, 2025 and 2024, respectively. The Company expects these expenses to continue to increase as it expands research and development activities to increase the use of environmentally-friendly materials and develop more new high-tech products to meet customer demands. Net loss increased by approximately $3.4 million, or 185.0%, from about $1.8 million for the six months ended December 31, 2024, to approximately $5.2 million for the six months ended December 31, 2025. About Dogness Dogness (International) Corporation was founded in 2003 from the belief that pet dogs and cats are important, well-loved family members. Through its smart products, hygiene products, health and wellness products, and leash products, Dogness is able to simplify pet lifestyles, make them more scientific, and enhance the relationship between pets and pet caregivers. The Company ensures industry-leading quality through its fully integrated vertical supply chain and world-class research and development capabilities, which has resulted in over 200 patents and patents pending. Dogness products reach families worldwide through global chain stores and distributors. For more information, please visit: ir.dogness.com . Forward Looking Statements No statement made in this press release should be interpreted as an offer to purchase or sell any security. Such an offer can only be made in accordance with the Securities Act of 1933, as amended, and applicable state securities laws. Certain statements in this press release concerning our future growth prospects are forward-looking statements regarding our future business expectations intended to qualify for the "safe harbor" under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the impact of U.S. tariffs policy on our exports to the United States and related effects on our price competitiveness and overall profitability, our ability to raise capital on any particular terms, fulfillment of customer orders, fluctuations in earnings, fluctuations in foreign exchange rates, our ability to manage growth, our ability to realize revenue from expanded operation and acquired assets in China and the U.S., our ability to attract and retain highly skilled professionals, client concentration, industry segment concentration, reduced demand for technology in our key focus areas, our ability to successfully complete and integrate potential acquisitions, and unauthorized use of our intellectual property and general economic conditions affecting our industry. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings. These filings are available at www.sec.gov . Dogness may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company's filings with the Securities and Exchange Commission and our reports to shareholders. In addition, please note that any forward-looking statements contained herein are based on assumptions that we believe to be reasonable as of the date of this press release. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law. For more information please contact: WFS Investor Relations Inc Connie Kang, Partner Email: ckang@wealthfsllc.com Tel: +86 1381 185 7742 (CN) DOGNESS (INTERNATIONAL) CORPORATION CONSOLIDATED BALANCE SHEETS (All amounts in USD) As of December 31, 2025 As of June 30, 2025 (Unaudited) ASSETS CURRENT ASSETS Cash and cash equivalents $ 6,633,479 $ 12,831,485 Accounts receivable-third-party, net 1,379,534 1,302,189 Accounts receivable-related party - 12,135 Inventories, net 2,293,311 2,719,790 Due from a related party 126,300 108,387 Prepayments and other current assets 3,030,798 3,497,688 Total current assets 13,463,422 20,471,674 NON-CURRENT ASSETS Property, plant and equipment, net 63,373,780 58,259,795 Intangible assets, net 1,761,959 1,748,755 Long-term investments in equity investees 20,015,853 20,656,752 Operating lease right-of-use lease assets 12,989,658 13,166,788 Deferred tax assets 2,846,502 2,542,822 Total non-current assets 100,987,752 96,374,912 TOTAL ASSETS $ 114,451,174 $ 116,846,586 LIABILITIES AND EQUITY CURRENT LIABILITIES Short-term bank loans $ 715,000 $ 698,000 Current portion of long-term bank loans 2,316,411 1,324,854 Accounts payable 1,616,434 1,593,590 Accounts payable - related party 51,294 22,663 Due to a related party 117,202 32,171 Contract liabilities 264,183 187,846 Taxes payable 568,702 566,682 Operating lease liabilities, current 663,364 197,130 Accrued expenses and other current liabilities 1,369,078 1,482,981 Total current liabilities 7,681,668 6,105,917 NON-CURRENT LIABILITIES Long-term bank loans 652,706 2,035,353 Operating lease liabilities, non-current 10,975,856 10,952,491 Total non-current liabilities 11,628,562 12,987,844 TOTAL LIABILITIES 19,310,230 19,093,761 Commitments and Contingencies (Note 13) EQUITY Class A Common shares, no par value, unlimited shares authorized; 5,441,658 and 5,161,658 issued and outstanding as of December 31, 2025 and June 30, 2025, respectively 117,636,230 117,349,730 Class B Common shares, no par value, unlimited shares authorized; 9,069,000 issued and outstanding as of December 31, 2025 and June 30, 2025 18,138 18,138 Statutory reserve 291,443 291,443 Accumulated deficit (15,667,948) (10,492,946) Accumulated other comprehensive loss (7,136,963) (9,413,583) Equity attributable to owners of the Company 95,140,900 97,752,782 Non-controlling interest 44 43 Total equity 95,140,944 97,752,825 TOTAL LIABILITIES AND EQUITY $ 114,451,174 $ 116,846,586 DOGNESS (INTERNATIONAL) CORPORATION STATEMENTS OF LOSS AND COMPREHENSIVE LOSS (All amounts in USD) (Unaudited) For the Six Months Ended December 31, 2025 2024 Revenue $ 7,710,901 $ 12,085,711 Cost of revenue 6,843,935 8,668,552 Gross Profit 866,966 3,417,159 Operating expenses: Selling expenses 1,234,204 624,410 General and administrative expenses 3,437,429 4,312,486 Research and development expenses 533,477 665,494 Impairment of investment in equity investee 1,123,200 - Total operating expenses 6,328,310 5,602,390 Loss from operations (5,461,344) (2,185,231) Other income (expense): Interest income, net 83,438 6,884 Foreign exchange transaction (loss) gain (151,611) 114,443 Other (expenses) income, net (13,613) 41,357 Rental income from related parties, net 129,856 107,737 Total other income, net 48,070 270,421 Loss before income tax (5,413,274) (1,914,810) Income tax benefit (238,272) (98,967) Net loss (5,175,002) (1,815,843) Less: net income attributable to non-controlling interest - - Net loss attributable to Dogness (International) Corporation (5,175,002) (1,815,843) Other comprehensive loss Foreign currency translation adjustments 2,276,621 (300,478) Comprehensive loss (2,898,381) (2,116,321) Less: comprehensive income attributable to non- controlling interest 1 - Comprehensive loss attributable to Dogness (International) Corporation $ (2,898,382) $ (2,116,321) Loss per share Basic and diluted $ (0.29) $ (0.14) Weighted Average Shares Outstanding Basic and diluted 17,807,886 12,755,658 DOGNESS (INTERNATIONAL) CORPORATION CONSOLIDATED STATEMENTS OF CASH FLOWS (All amounts in USD) (Unaudited) For the Six Months Ended December 31, 2025 2024 Cash flows from operating activities: Net loss $ (5,175,002) $ (1,815,843) Adjustments to reconcile loss income to net cash (used in) provided by operating activities: Depreciation and amortization 1,360,710 1,395,756 Share-based compensation 286,500 399,470 Change in inventory reserve 688,689 - Loss from disposal of property, plant and equipment - 176,347 Reversal of allowance for credit losses (31,553) (232,600) Impairment of long-term investment 1,123,200 - Deferred tax benefit (238,652) (108,490) Amortization of right-of-use lease assets 488,760 585,466 Changes in operating assets and liabilities: Accounts receivable-third parties (3,983) (824,001) Accounts receivable-related party 2,910 272,429 Inventories (208,212) (121,257) Due from a related party (14,995) (4,959) Prepayments and other current assets (30,691) (61,720) Advances to supplier-related party - 51,537 Accounts payable (15,678) 999,703 Accounts payable-related party 27,568 13,130 Accrued expenses and other current liabilities (147,295) 24,691 Contract liabilities 70,460 (39,639) Operating lease liabilities 214,082 200,827 Taxes payable (11,568) 26,242 Net cash (used in) provided by operating activities (1,614,750) 937,089 Cash flows from investing activities: Purchase of property, plant and equipment (4,386,993) (1,050,711) Proceeds from disposition of property, plant and equipment - 787 Net cash used in investing activities (4,386,993) (1,049,924) Cash flows from financing activities: Proceeds from short-term bank loans 702,000 696,500 Repayment of short-term bank loans (702,000) (696,500) Repayment of long-term bank loans (464,331) (316,297) Proceeds from (repayment of) related party loans 82,716 (451,201) Net cash used in financing activities (381,615) (767,498) Effect of exchange rate changes on cash and restricted cash 185,352 (18,339) Net decrease in cash and cash equivalents (6,198,006) (898,672) Cash and cash equivalents, beginning of period 12,831,485 6,956,434 Cash and cash equivalents, end of period $ 6,633,479 $ 6,057,762 SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Cash paid for interest $ 71,272 $ 115,430 Non-Cash Investing Activities Liabilities incurred for purchase of property and equipment $ - $ 34,909
2026-04-02 01:00:00

LEIFRAS Co., Ltd. and Sanko Gakuen to Sign Comprehensive Partnership Agreement to Develop Next-Generation Sports Business Talent
Industry-Academia Collaboration Aims to Address the Growing Shift of School Club Activities to Local Communities TOKYO , April 2, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and community engagement, today announced that on March 13, 2026, it entered into a comprehensive partnership agreement (the "Agreement") with Sanko Gakuen Educational Corporation ("Sanko Gakuen"), a nationwide operator of vocational schools and other institutions in Japan, to develop next-generation sports business talents. The Agreement will become effective on April 1, 2026. By combining the resources of both parties, the partnership will provide practical learning and career opportunities for students seeking to enter the sports industry. The partnership is designed to cultivate talents who will contribute to solving social issues, such as the worsening shortage of sports instructors, and supporting Japan's transition of school club activities to local communities. Background of the Agreement: Urgent Need to Develop the Next Generation of Sports Talent Japan's sports education environment is currently at a turning point. In particular, the government's initiative to "shift club activities to local communities" is reducing the burden on teachers, but the shortage of high-quality sports instructors and management personnel who can support local communities is becoming a serious social issue. In response, Leifras, which has an established track record of operating sports schools nationwide, and Sanko Gakuen, which has diverse human resource development know-how, have teamed up to launch this practical industry-academia collaboration project to develop the sports industry and contribute to local communities. Collaboration Overview: Providing Practical Learning Experience The collaboration will provide students at Sanko Gakuen with practical experience in "real sports business and coaching situations" beyond traditional classroom learning. The main details of the collaboration are as follows: On-site internships and participation in local joint projects: Students of Sanko Gakuen will have the opportunities to participate in internships at facilities operated by Leifras and directly in the planning and management of local joint projects, gaining direct exposure to operational practices in the sports industry. Joint operation of a sports school utilizing campus facilities: Leifras plans to operate its sports school at Sanko Gakuen's facilities, providing students with a place to gain practical coaching experience. Providing a career path for club activity instructors: Students who complete the "Bukatsu Seminar" e-learning course for training club activity instructors will have opportunities to connect with and be guided by Leifras' nationwide club activity support business, providing them with direct opportunities to work after graduation. Collaboration in public relations and recruitment activities: Leifras and Sanko Gakuen also plan to collaborate in recruiting students who are interested in careers in the sports industry. Both parties have agreed to the mutual use of each other's logos in such activities. Sanko Gakuen has also agreed to invite Leifras as a guest at open campus events. Future Outlook: Realizing Sustainable Development of Local Communities Through Sports Through this collaboration, Leifras intends to establish a sustainable pipeline of sports industry professionals who can contribute to local communities through the power of sports. The Company plans to continue to deepen its collaboration with educational institutions and promote social business to support the transformation of Japan's sports education environment into a sustainable one. Summary of the Agreement Agreement name: Comprehensive collaboration agreement on developing next-generation sports business talent Signing date: March 13, 2026 Signed by: Kiyotaka Ito, CEO of Leifras Co., Ltd., and Satoshi Torii, Chairman of the Board of Sanko Gakuen Educational Corporation About Sanko Gakuen Educational Corporation Sanko Gakuen Educational Corporation is a comprehensive educational corporation group that operates vocational schools, universities, junior colleges, high schools, and childcare facilities nationwide, with the educational philosophy of "harmony between skills and mind." Sanko Gakuen cultivates work-ready professionals through practical education in a wide range of fields, including sports, medicine, welfare, beauty, bridal, childcare, and IT. Corporate name: Sanko Gakuen Educational Corporation Address: 23-16 Hongo 3-chome, Bunkyo-ku, Tokyo Representative: Chairman Satoshi Torii Established: March 1985 Business details: Operation of vocational schools, universities, junior colleges, high schools, childcare facilities, etc. Official website: https://www.sanko.ac.jp/ . About LEIFRAS Co., Ltd. Headquartered in Tokyo, Leifras is a sports and social business company dedicated to youth sports and community engagement. The Company primarily provides services related to the organization and operations of sports schools and sports events for children. As of December 31, 2024, Leifras was recognized as one of Japan's largest operators of children's sports schools in terms of both membership and facilities by Tokyo Shoko Research. The Company's approach to sports education emphasizes the development of non-cognitive skills, following the teaching principle "acknowledge, praise, encourage, and motivate." The holistic approach that integrates physical and mental development sets Leifras apart in the industry. Building upon deep experience and know-how in sports education, Leifras also operates a robust social business sector, dispatching sports coaches to meet various community needs with the aim to promote physical health, social inclusion, and community well-being across different demographics. For more information, please visit the Company's website: https://ir.leifras.co.jp/ . Forward-Looking Statements Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can find many (but not all) of these statements by the use of words such as "approximates," "believes," "hopes," "expects," "anticipates," "estimates," "projects," "intends," "plans," "will," "would," "should," "could," "may," or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. These statements are subject to uncertainties and risks, including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the "Risk Factors" section of the registration statement filed with the U.S. Securities and Exchange Commission (the "SEC"). Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the registration statement and other filings with the SEC. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov . For more information, please contact: LEIFRAS Co., Ltd. Investor Relations Department Email: IR@leifras.co.jp Ascent Investor Relations LLC Tina Xiao Phone: +1-646-932-7242 Email: investors@ascent-ir.com
2026-04-02 01:00:00

Free Tickets Open for 2026 Medtec
SHANGHAI , April 2, 2026 /PRNewswire/ -- Free tickets for 2026 Medtec open on April 1, 2026. Visitors who complete registration before August 31 can enter free of charge. As Asia's Leading Medical Device Supply Chain Expo — From R&D to Commercial Manufacturing , 2026 Medtec will be held from September 1–3, 2026, at the Shanghai New International Expo Centre (SNIEC), Pudong, Halls N1–N4. On-site registration during the exhibition will incur a 100 RMB admission fee per person. 2026 Medtec free ticket https://visitorreg.medteccn.com/medtec-en/?utm_medium=pressrelease&utm_source=prnewswire&utm_campaign=register_open&utm_content=en Visit the official website now to claim your free ticket and stay ahead in the industry! Free Tickets Now Open (April 1 – August 31, 2026) Free tickets are open through August 31, 2026, offering visitors a more efficient way to plan their visit to 2026 Medtec. Early Registration Benefits: Free access (save up to 100 RMB per person) Support for international group registration Fast-track entry with no on-site queue Flexible visit scheduling 2026 Medtec Overview Marking its 20th edition, Medtec continues to serve as a comprehensive platform across the full medical device R&D and manufacturing chain, with an exhibition area of 47,000 square meters, 1,100 exhibitors, and an estimated 93,000 visits. The exhibition provides integrated solutions across R&D, prototyping, manufacturing, certification, mass production, OEM services, and CRO and CDMO capabilities. Exhibits span a wide range of categories, including materials, core components, electronic parts, optical components, surface processing, precision machining, automation equipment, packaging, sterilization, testing, and consulting services. The exhibition will be organized across four halls at SNIEC, spanning N1-N4.The four halls are structured around key segments of the medical device supply chain, from materials and core components to manufacturing services and equipment. Halls N1–N2 focus on Medical Materials & Core Components. Hall N1 Highlights: Metal Materials and Their Components Orthopedic and Dental Implant Processing Zone Ceramics, Biomaterials, Glass, and Other Materials and Related Components Ultra-precision Laser Processing, Machine Tools and Additive Manufacturing Hall N2 Highlights: Medical Rubber and Plastic Materials and Their Components Bonding Agents, Bonding Products IVD Reagents, Filtration, Intravenous Injection, and Laboratories Pipe Fittings and Extrusion Pharmaceutical Delivery Systems, Dressing Materials and Formulation Processing Halls N3–N4 focus on Medical Manufacturing Service & Equipment. Hall N3 Highlights: Plastic Film Molding Services and Equipment OEM/ODM Contract Manufacturing Services Medical Automation, Drive Control, Robotics, Smart Factory Pipe Fittings and Extrusion Equipment Surface Treatment Hall N4 Highlights: Medical Packaging, Sterilization, Labeling, Cleanroom R&D and Design, Software Services, and Consulting Services Exhibition of Testing, Metrology, Inspection and Calibration Equipment and Supplies Integrated Service Area Visitor Composition Medtec's core visitor base includes medical device manufacturers, supply chain companies, and import-export enterprises. Attending representatives span senior executives, directors, engineers, managers, supervisors, and specialists. Their responsibilities cover management, R&D and technical centers, process and manufacturing engineering, quality, supply chain and procurement, as well as regulatory affairs. It also attracts professionals from hospitals, clinics, and public health institutions, including hospital administrators, department directors and deputy directors, attending physicians, and other healthcare personnel. In addition, researchers and professors from research institutes and universities in medical device-related fields are expected to attend, alongside investors and analysts from the healthcare sector. 2026 Medtec will continue to attract participation from the industry's top buyer companies. Conclusion As a key platform for leading companies to launch new products and showcase cutting-edge technologies, Medtec brings together a full spectrum of materials, components, manufacturing equipment, and supporting services. It supports one-stop sourcing while helping global companies connect with the China market. Free tickets for 2026 Medtec open on April 1 and close on August 31, 2026 — register in advance to secure free admission. Media Contact Website: https://en.medtecchina.com/ Talia Li, talia.li@informa.com Booth Enquiry: LINC, +86 21 6157 7217, linc.cai@informa.com Visitor and Media Enquiry: Tracy, +86 10 6562 3307, tracy.zhang@informa.com
2026-04-02 01:00:00

Трамп грубо описал свои отношения с наследным принцем Саудовской Аравии
Президент США Дональд Трамп резко охарактеризовал свои отношения с наследным принцем Саудовской Аравии Мухаммедом бин Салман Аль Саудом на форуме Future Investment Initiative. Как передает Vesti.az со ссылкой на РБК, прямую трансляцию вел Белый дом на YouTube. По его словам, саудовский принц недооценивал его. Тот думал, что Трамп будет «очередным американским президентом, при котором страна катится под откос». «Он не думал, что такое возможно. Он не думал, что будет целовать меня в зад. Серьезно, не думал», — заявил лидер США. В начале марта The Washington Post со ссылкой на источники писала, что Саудовская Аравия и Израиль много недель подталкивали Трампа к удару по Ирану. По данным издания, республиканец принял решение о начале начале военной операции после многочисленных звонков наследного принца страны Мухаммеда бин Салмана Аль Сауд и публичной кампании премьер-министра Израиля Биньямина Нетаньяху.
2026-03-28 18:49:55

Бейрут объявил посла Ирана персоной нон грата
Ливан объявил иранского дипломата персоной нон грата и потребовал его выезда из страны на фоне нарастающей напряженности в регионе. Как сообщает Vesti.az со ссылкой на АПА, министр иностранных дел Ливана Юсеф Раджи сообщил в социальной сети X, что иранский дипломат Мохаммед Реза Шибани лишен аккредитации и должен покинуть территорию страны до 29 марта. «Сегодня я поручил Генеральному секретарю Министерства иностранных дел и по делам мигрантов вызвать временного поверенного в делах Ирана в Ливане и сообщить ему об отзыве аккредитации...», — говорится в заявлении. Кроме того, ливанская сторона отозвала своего посла в Иране для консультаций, обвинив Тегеран в нарушении дипломатических норм и устоявшейся практики взаимодействия между двумя государствами. Решение принято на фоне продолжающегося обострения ситуации на Ближнем Востоке.
2026-03-24 12:37:34

Ping An Good Doctor Reports 2025 Annual Results: Corporate Health Management Business Posts Strong Growth; AI Healthcare Deployment Accelerates
HONG KONG , March 24, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or the "Company"; Stock Code: 1833.HK) announced its annual results for the year ended December 31, 2025. In 2025, the Company recorded total revenue of RMB5.47 billion, up 13.7% year on year; profit attributable to owners of the parent of RMB379.5 million, up 366.1% year on year; and adjusted net profit of RMB414.0 million, up 161.3% year on year. Meanwhile, the Company's revenue mix continued to improve. Revenue from the commercial insurance enablement business (F-end) reached RMB3.3 billion, representing a year-on-year increase of 11.0%. The corporate health management business (B-end) delivered particularly strong growth, with revenue surging 40.6% year on year to RMB1.3 billion, accounting for 23.9% of total revenue, up 4.6 percentage points year on year. As the core flagship of Ping An Group's health and senior care strategic business segment, the Company aims to build a managed care model with Chinese characteristics. It continued to upgrade its "online, in-hospital, in-home, and in-company" service network and empower full-scenario services through medical AI, providing users with one-stop medical, health, and senior care solutions that are worry-free, time-saving, and money-saving. Core Businesses Unlock Profit Potential, Accelerating the Development of a China-style HMO Model In the commercial insurance enablement business , Ping An Good Doctor provides Ping An Group's retail customers with online and offline, one-stop, 24/7, proactive medical, health, and senior care services, helping Ping An Group's integrated finance business enhance the differentiated competitiveness of its products, support customer acquisition and retention, and increase customer value. During the period, first-year premium per new policy of health care customers and home-based senior care customers increased by 1.5 times and 4.6 times, respectively. Meanwhile, the Company continued to deepen innovation in the insurance + health care synergies, promoting the further integration of membership services and insurance products. For customers with protection products such as critical illness and medical insurance, the Company launched the "An You Hu"(安有護) and "An You Yi"(安有醫) health service plans. For customers with wealth-management insurance products, it established a multi-tiered membership system. For example, under the "Yu Xiang Guo Yi" program designed for high-value customers, the Company developed an integrated traditional Chinese and Western medicine co-management solution featuring one-on-one consultations with Traditional Chinese Medicine masters, personalized conditioning plans, and full-process management and proactive follow-ups by TCM family doctors. For pension insurance customers, the Company continued to upgrade its home-based senior care service system, introducing three service programs covering health care management, home safety assistance and professional care for seniors. As of the end of the reporting period, more than 240,000 customers were entitled to home-based senior care services. On the corporate health management side , leveraging differentiated strengths such as professional experience in corporate health management, a global medical service network, global emergency assistance, professional in-company services, 24/7 family doctor consultations, and convenient in-home services, the Company continued to expand its corporate customer base and provide one-stop health management solutions for corporates. To date, Ping An Good Doctor has served more than 6,700 paying corporate clients, up 83.1% from a year earlier. At the same time, this business generated gross merchandise volume (GMV) of approximately RMB3.63 billion in 2025, further unlocking its commercial potential. During the reporting period, the Company provided each enterprise with tailored solutions, including Workplace Clinics, in-company activities, and digital health dashboards. Employees have access to full-scenario services such as health checkups, chronic disease management, medical visit assistance, consultations with renowned doctors, and convenient medication purchase. Meanwhile, its QR code payment service, "Ping An Health Pay" has been rolled out to more than 77,000 pharmacies, improving convenience and saving time for employees. Strengthening "online, in-hospital, in-home, and in-company" Service Capabilities to Build a Full-scenario Closed Loop Value Chain In 2025, the Company continued to improve its "online, in-hospital, in-home, and in-company" service system, further expanding its service network and enhancing service quality. Online services , the Company leveraged traffic from Ping An Group's health and senior care ecosystem and external corporate clients and has upgraded its multi-tiered family doctor service system to provide policyholders and corporate employees with full-cycle, proactive health management services, while offering differentiated solutions for customers with different health conditions. During the period, chronic disease management services were used 16.9 million times, with customer satisfaction reaching 99%. In-hospital services , the Company further expanded its offline service network and built a team of approximately 50,000 in-house and contracted external doctors. It has signed up more than 3,500 expert doctors in total, including 10 academicians / TCM masters and over 800 hospital presidents, vice hospital presidents, department heads, and discipline leaders. The Company also partnered with more than 5,100 hospitals, over 240,000 pharmacies, and over 4,400 health checkup providers. In-home services , the Company's home-based senior care services have expanded to 100 cities nationwide. During the period, the average monthly active rate of home-based senior care services reached 84%, while the response rate of "Smart Guard" alarms reached 100%. In-company services , the Company continued to build multiple Workplace Clinics with services such as health monitoring, consultation and physiotherapy, and health education. Through remote screens for health services, the Company provides employees with a face-to-face consultation experience, and connects resources across the "online, in-hospital, in-home, and in-company" service network, effectively addressing pain points such as uneven access to medical resources across regions. In addition, the Company continued to advance service standardization. In family doctor services, it supported the release of China's first group standard in online family doctor services, the Remote and Internet-Based Health Service Standards for Family Doctors . In home-based senior care, the Company has contributed to the development of six industry group standards, including the Service Management Standards for Home-based Rehabilitation and Nursing . Ping An's home-based senior care service was also among the first to receive the five-star rating for "home-based eldercare steward" services from the China Quality Certification Centre (CQC). In chronic disease management, the Company participated in the development of the national group standard for Specifications for the Construction of Weight Management Centers , supporting the standardized development of the weight management industry. Leading AI Adoption in Healthcare to Boost Gross Profit and Improve Efficiency With continued policy support in China for the development of "AI + Healthcare" applications, AI healthcare has entered a stage of scaled deployment. Backed by its deep technological expertise, Ping An Good Doctor continued to improve its AI capabilities, strengthen its "data + model + scenario" closed-loop capabilities, and expand AI deployment across various healthcare service scenarios, with the benefits of AI empowerment becoming increasingly evident. The Company continued to deepen its presence in serious medical scenarios, building a differentiated model that combines AI with human doctors. During the reporting period, it further upgraded its large multi-modal model Ping An Medical Master®, as well as five vertical AI models for key medical scenarios. It also launched an AI medical product suite including key products such as Renowned Doctor Digital Avatar, AI Family Doctor, and AI Senior Care Concierge, with over 11,300 diseases precisely diagnosed and an accuracy rate of 95.1% in AI Doctor-aided diagnosis/treatment. It also introduced the multidisciplinary team ("MDT") platform for complex diseases, which has already been deployed in breast cancer and other disease areas. The accuracy of MDT treatment plans for complex diseases approached 90%, and the platform will be extended to more disease areas in the future. During the reporting period, AI delivered notable empowerment in user reach, gross profit growth, and operating efficiency. Annual users of AI Doctor reached nearly 12 million, and the "AI + human doctor" model achieved 100% coverage among Ping An Group's retail customers; AI contributed approximately 4.5% of the Company's gross profit. Taking consultation services as an example, with AI's support, the cost per consultation in the fourth quarter of 2025 decreased by approximately 45% year on year, reflecting AI's role in improving efficiency and reducing service costs. As public health awareness in China continues to rise and population aging accelerates, demand for high-quality medical resources is expected to keep growing, creating greater opportunities for the medical and health industry. Looking ahead, with continued support from various favorable policies, the Company will remain focused on providing inclusive, high-quality medical, health and senior care services that are worry-free, time-saving and money-saving, while delivering sustainable returns to shareholders. About Ping An Healthcare And Technology Company Limited Incorporated in 2014, Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", 1833.HK) is a flagship of Ping An Group's health and senior care ecosystem. The Company was listed on the main board of HKEX on 4 May 2018. The Company is dedicated to advancing Ping An Group's "integrated finance + health and senior care" strategy. Leveraging its extensive payer resources of health and senior care services, broad service provider network, comprehensive service standards, and robust ecosystems, the Company has evolved into a leading provider of health and senior care management services. The Company remains steadfast in its mission to bridge professional communication between doctors and patients and to provide health improvements for all. Guided by the vision of "providing every enterprise with a healthy workplace, every family with a dedicated doctor, and every user with a healthy, long life," the Company will accelerate the development of a China-style HMO Model, providing users with a "worry-free, time saving, and money-saving" one-stop medical, health, and senior care solution.
2026-03-24 12:37:00

RiseLink Redefines Edge AI with the BK7259 "Powerhouse" and R2 Unified AI Developer Platform at Embedded World 2026
NUREMBERG , Germany , March 11, 2026 /PRNewswire/ -- RiseLink Technologies, a global leader in low-power connectivity with a 20-year legacy in semiconductor innovation, today announced the launch of its BK7259 Edge AI powerhouse at Embedded World 2026. As the centerpiece of the new R2 Unified AI Developer Platform , the BK7259 is designed to move intelligence from the cloud directly onto hardware, enabling a new generation of autonomous, secure, and reliable smart terminals. The BK7259: An Edge AI Powerhouse The BK7259 is a highly integrated cognitive hub built on a single die, replacing the inefficient multi-chip hardware stacks of the past. By combining high-definition video, advanced audio, precise motor control, and dedicated AI processing in one platform, RiseLink provides the "body and nervous system" of intelligent devices so developers can focus on building the unique "soul" of their products. Key features include: Powerful local compute: Dual Cortex-M55 cores and an Arm Ethos-U65 microNPU delivering 0.3 TOPS of AI acceleration Unified memory architecture: Enables the NPU, GPU, and CPU to operate simultaneously without frame drops, supporting real-time tracking and natural language processing Privacy and security: Supports fully on-device 3D face recognition in under 200 ms, ensuring biometric data never leaves the device Ultra-low power consumption: Achieves less than 60 μA keep-alive current and 2 μA deep sleep current, making high-performance AI possible on a single battery The R2 Unified AI Developer Platform Alongside the BK7259, RiseLink is debuting the R2 Unified AI Developer Platform , designed to reduce friction and accelerate intelligent product development. Platform highlights include: Rapid prototyping: Verified drivers for popular sensors including GC2145 and OV2640, as well as support for specialized circular displays such as ST7701S Standardized tools: Built on the Armino SDK with support for CMSIS-NN and TensorFlow Lite Micro, enabling streamlined deployment across diverse workloads Interactive community: Supported by RiseLink's Reddit forum and Discord channel, where developers can collaborate directly with RiseLink engineers Vision and Leadership at Embedded World 2026 RiseLink's presence at Embedded World 2026 is further highlighted by leadership engagements at the event: Exhibitor's Forum talk: CEO Dr. Pengfei Zhang will present "From Hearing to Seeing: Powering Battery-First Embodied AI with the BK7259" at the Exhibitor Forum in Hall 3 / Booth 3-611 on Thursday, March 12 , at 14:30 Media spotlight: Diana Zhu , Head of the United States for RiseLink, was featured in an Embedded World 2026 video interview discussing RiseLink's commitment to delivering more compute with lower power consumption for the global smart home ecosystem Strategic Showcase with Tuya Smart RiseLink continues its long-term collaboration with Tuya Smart (NYSE: TUYA; HKEX: 2391) to support scalable intelligent device infrastructure. At Embedded World 2026, the companies are jointly showcasing: T5 AI Series products: Including the T5 AI board, a developer kit with integrated microphones and cameras for deploying LLM agents and AI-driven toys Smart home and smart energy solutions: Featuring Tuya smart locks with local 3D face recognition to keep biometric data secure and private, as well as Tuya's all-in-one smart energy-saving solution, which uses AI-driven 24/7 monitoring and threshold alerts to improve energy efficiency and cost-effectiveness Visit RiseLink at Embedded World 2026 Location: Hall 3, Booth 3-656 Experience: Live demonstrations of the BK7259 Edge AI powerhouse and the R2 Unified AI Developer Platform About RiseLink Technologies RiseLink is a chip design company shipping over 300 million chips annually. Its technology powers products for global brands including Samsung, LG, Haier, and Midea. About Tuya Smart Tuya Smart is a global AI cloud platform service provider that enables businesses to rapidly build smart commercial solutions across energy, real estate, and other industries.
2026-03-11 15:18:00

Donald Tramp Rusiya Prezidentinə zəng edib YENİLƏNİB
ABŞ Prezidenti Donald Tramp Rusiya Prezidenti Vladimir Putinə telefonla zəng edib.AZƏRTAC xəbər verir ki, bu barədə jurnalistlərə Rusiya Prezidentinin köməkçisi Yuri Uşakov məlumat verib. Onun sözlərinə görə, söhbətdə əsas diqqət İran ətrafındakı vəziyyətə, həmçinin ABŞ nümayəndələrinin iştirakı ilə Ukrayna münaqişəsinə dair aparılan üçtərəfli danışıqlara yönəldilib.Yuri Uşakov bildirib ki, telefon danışığı zamanı Putin İran münaqişəsinin mümkün qədər tez siyasi-diplomatik yolla tənzimlənməsinə yönəlmiş bir sıra fikirlərini səsləndirib. O, İran Prezidenti və bir sıra digər dövlət rəhbərləri ilə apardığı danışıqlar barədə məlumat verib.Öz növbəsində Donald Tramp ABŞ və İsrail tərəfindən həyata keçirilən əməliyyatın gedişatından danışıb. Uşakovun sözlərinə görə, liderlər arasında bu mövzuda konkret və faydalı fikir mübadiləsi aparılıb. Bundan əlavə, Yuri Uşakov bildirib ki, ABŞ Prezidenti Ukraynadakı münaqişənin tezliklə atəşkəslə və uzunmüddətli siyasi həll yolu ilə başa çatdırılmasında maraqlı olduğunu bir daha ifadə edib. Telefon danışığı zamanı Rusiya tərəfi Donald Trampın komandası və onun şəxsi vasitəçilik səylərinə müsbət qiymət verib.23:36Rusiya Prezidenti Vladimir Putin amerikalı həmkarı Donald Trampla telefon danışığı aparıb.AZƏRTAC xəbər verir ki, bu barədə Rusiya Prezidentinin beynəlxalq məsələlər üzrə köməkçisi Yuri Uşakov jurnalistlərə bildirib.Qeyd edək ki, bu, Putin və Tramp arasında son iki aydan artıq müddətdə baş tutan ilk telefon danışığıdır. Həmçinin bu, ABŞ və İsrailin İrana hücumundan sonra tərəflər arasında qeydə alınan ilk məlum təmasdır.
2026-03-10 05:19:10

Ким Чен Ын высказался о дружбе с КНДР
КНДР будет укреплять дружбу и связи с Китаем, говорится в телеграмме, направленной лидером страны Ким Чен Ыном председателю КНР Си Цзиньпину.Как передает Vesti.az, об этом сообщило Центральное телеграфное агентство Кореи (ЦТАК).Ким Чен Ын поблагодарил китайского коллегу за поздравления в связи с его переизбранием на пост генерального секретаря Трудовой партии Кореи (ТПК) на IX съезде ТПК."Дальше укреплять и развивать традиционную корейско-китайскую дружбу в соответствии с велением новой эпохи и стремлениями народов двух стран - такова незыблемая позиция нашей партии и правительства республики. Рассчитываю, что на пути к продвижению совместного социалистического дела взаимодействие между двумя партиями, двумя странами - КНДР и КНР - будет более тесным", - говорится в телеграмме.
2026-03-10 05:18:13

Xiamen C&D Inc.'s New Five-Year Strategic Plan Released, Aiming to Accelerate Globalization
XIAMEN, China, March 5, 2026 /PRNewswire/ -- In January 2026, Xiamen C&D Inc. (stock code: 600153.SH) officially released its 2026–2030 strategic plan for its supply chain operations. Over the next five years, the company will focus on three strategic goals: improving economic efficiency, strengthening market position, and expanding overseas scale. It will also enhance five core competencies: specialization, internationalization, digitalization, foresight, and resource capabilities. Through these efforts, Xiamen C&D Inc. aims to shift from a scale-driven model toward a dual-engine growth model powered by efficiency and innovation. According to the plan, Xiamen C&D Inc. will focus its efforts on the following five areas.: (1) Stick to specialized operations and promote differentiated management; (2) Accelerate its international footprint while deepening localized operations; (3) Strengthen digital and intelligent capabilities to empower the supply chain ecosystem; (4) Enhance endogenous foresight and optimize overall resource capabilities; (5) Reinforce innovation-driven development and cultivate a second growth curve to inject new momentum for the company's long-term growth. Over the next five years, Xiamen C&D Inc. will consolidate its operations through specialization, expand growth potential through internationalization, improve efficiency through digitalization, address cyclical challenges with internal foresight, and reinforce competitiveness through resource capabilities. By doing so, the company will strive to move from "domestically excellent" to "internationally leading" and achieve high-quality development.
2026-03-05 23:00:00

LiuGong at CONEXPO 2026 | Electric and Integrated Solutions
LAS VEGAS, March 6, 2026 /PRNewswire/ -- LiuGong (000528.SZ) presented 13 machines across multiple product lines at CONEXPO-CON/AGG 2026 under the theme "Tough Customers. Tough Equipment," covering applications from urban construction to quarrying, mining, and large-scale infrastructure projects. Group Photo at LiuGong Booth, CONEXPO 2026 Electric Solutions for Lower Operating Costs Among the featured machines were the zero-emission 922FE excavator, 870HE & 820TE wheel loaders, representing LiuGong's expanding electric portfolio in the American market. These machines offer more than 40% lower operating costs through reduced wear parts, fluids and filters, and simplified maintenance. Their quiet operation and instant torque make them suitable for urban construction, demolition, and emissions-sensitive public sector projects. LiuGong electric equipment now operates in over 60 countries, with cumulative sales exceeding 60,000 units. Diesel Equipment for High-Production Applications For heavy-duty applications, LiuGong showcased the 952F excavator and 856T wheel loader powered by Cummins Tier 4 Final / Stage V engines. Designed for quarrying, mining, and large-scale infrastructure projects, these machines emphasize durability and continuous operation in demanding and remote environments. Precision Equipment That Protects Project Margins LiuGong also presented specialty equipment such as the 4215D motor grader and 6608F roller, highlighting its capabilities in precision grading and compaction. Advanced grading accuracy and integrated compaction technologies help reduce rework associated with material removal, pavement replacement, and crew remobilization, enabling customers to maintain schedules and control operating costs. Unified Equipment Ecosystem The addition of the TD16N Dozer completes LiuGong's product coverage across major earthmoving categories. Standardized telematics and diagnostic systems enable consistent monitoring and service support across multiple machine types, simplifying fleet management and aftersales operations. Customer Engagement In addition to the equipment display, LiuGong hosted its onsite podcast series "Tough Customer Talk" at Booth F18033, featuring customers and dealers sharing real-world experiences and insights into LiuGong machines' performance, reliability, and their business impact. "Tough customers don't have time for complexity," said Andrew Ryan, President of LiuGong North America. "They need one partner they can rely on for the entire job—from the first dig to the final grade. Our goal is to deliver durable, efficient equipment supported through a unified service network." Creating Value Through Cooperation Four days prior to CONEXPO-CON/AGG, LiuGong North America held a two-day dealer conference, bringing together local dealers to discuss industry trends and future development strategies. Dealer representatives were also invited to share their market practices and success stories. The in-depth exchanges further strengthened partnerships and laid a solid foundation for continued market expansion. On Mar.4, LiuGong and Cummins marked 30 years of global cooperation. To date, more than 300,000 LiuGong machines worldwide have been equipped with Cummins engines, while Guangxi Cummins has produced over 300,000 engines since its establishment, reflecting the strength of the long-standing partnership. Commitment to the American Market On March 2, LiuGong held a press conference attended by nearly 50 prominent industry and mainstream media outlets. Luo Guobing, President of LiuGong; Li Dongchun, Vice President of LiuGong; and Andrew Ryan, President of LiuGong North America, announced the company's latest strategy and field questions from the press regarding industry trends and future development plans. Through its expanded portfolio and customer-focused engagement, LiuGong reaffirmed its long-term commitment to the local market. The company will continue to broaden its offerings to meet evolving jobsite requirements, delivering reliable and comprehensive solutions for a wide range of applications.
2026-03-05 22:56:00

Восстановление Украины оценивается более чем в 500 миллиардов евро
Спустя четыре года после начала вторжения России в Украину опубликован новый отчёт о стоимости восстановления страны. Согласно документу, обнародованному 23 февраля, в течение ближайших десяти лет на восстановление Украины потребуется около 588 миллиардов долларов (более 500 миллиардов евро).Как сообщает Vesti.az, отчёт был подготовлен совместно украинскими властями, Всемирный банк, Европейский союз и Организация Объединённых Наций. В документе отмечается, что эта сумма примерно в три раза превышает прогнозируемый ВВП Украины на 2025 год.Наибольшие финансовые потребности приходятся на транспортный сектор (96 млрд долларов), энергетику (77 млрд евро), жилищный фонд (77 млрд евро), торговлю и промышленность (54 млрд евро), а также сельское хозяйство (47 млрд евро). Особенно масштабные восстановительные работы предстоят в регионах интенсивных боевых действий — Донецкой и Харьковской областях.Расходы на восстановление столицы — Киев — оцениваются более чем в 12 миллиардов евро. Город с населением около 3 миллионов человек и площадью, сопоставимой с Берлином, регулярно подвергается атакам российских беспилотников и ракет.В отчёте подчёркивается, что гуманитарные, социально-экономические и экологические последствия российского вторжения будут ощущаться «на протяжении поколений». Поэтому восстановление Украины потребует не только реконструкции инфраструктуры, но и долгосрочного возрождения общества и экономики.
2026-02-23 23:42:00

Израиль требует полного разоружения ХАМАС
ХАМАС должен быть полностью разоружён.Как передает Vesti.az со ссылкой на AПA, об этом заявил министр иностранных дел Израиля Гидеон Саар на первом заседании «Совета мира» в Вашингтоне.Гидеон Саар отметил, что все предыдущие планы по Газе провалились, поскольку не устранили основные проблемы — террор, ненависть, подстрекательство и идеологическую обработку:«В центре всеобъемлющего плана президента Трампа стоит разоружение ХАМАС и "Исламского джихада", демилитаризация сектора Газа и дерадикализация палестинского общества. Это первый план, направленный на корни проблемы. Мы поддерживаем его и будем работать ради его успеха.ХАМАС должен быть полностью разоружён. Это должно включать ликвидацию всего его вооружения, террористической инфраструктуры, сети подземных туннелей и объектов по производству оружия.Как отмечено в плане, должен быть реализован серьёзный процесс дерадикализации. В образовательных и религиозных учреждениях больше не должно существовать инфраструктуры, прививающей палестинским детям ненависть и насилие в отношении евреев. Всё это важно не только для израильтян, но и для населения Газы. Народ Газы десятилетиями живёт под террористическим режимом, и он должен быть освобождён от этих террористов».
2026-02-19 18:09:59

Businesses Lean on Technology as Cross-Border Trade Grows More Uncertain, Avalara Finds
Avalara's 2026 Cross-Border Chaos Report shows that 83% of business leaders find international operations more complex, with 39% delaying market entry amid rising uncertainty. DURHAM, N.C., Feb. 17, 2026 /PRNewswire/ -- New research from Avalara, Inc., the agentic tax and compliance leader, shows that while businesses are eager to expand globally, fading confidence in stable trade rules is forcing many to slow or delay growth amid rising regulatory complexity, tariffs, and geopolitical volatility. Read Avalara's 2026 Cross-Border Chaos Report here. Avalara's 2026 Cross-Border Chaos Report reveals that 83%1 of business leaders believe cross-border operations are more complex than a year ago, while 70%2 say trade is more complex than it was three years ago. Nearly 4 in 10 companies (39%) have delayed entering new markets altogether due to regulatory uncertainty. As a result, global expansion is losing momentum, with just 43% of businesses actively pursuing new international opportunities. Tariffs, fragmented regulations, and geopolitical volatility are making cross-border operations increasingly unpredictable, costly, and complex. In response, businesses are turning to technology to create their own certainty. 87%3 of companies now use AI in some capacity for their cross-border operations. This suggests that automation and intelligent compliance systems are becoming central to managing risk, maintaining control, and sustaining growth. In addition, it points to a fundamental shift in global trade, where trust is moving towards systems that can adapt as quickly as the rules change. "Global expansion hasn't lost its appeal, but the rules of the game are changing faster than ever," said Craig Reed, GM of Cross-Border at Avalara. "As trade becomes more fragmented and unpredictable, businesses are realizing they can't wait for certainty to return. They're using technology and automation to stay compliant, manage risk, and keep moving forward." Other findings from the Cross-Border Chaos Report include: Compliance is core to growth: Once viewed as a back-office function, compliance is now a defining factor in expansion decisions. Nearly half of respondents (49%) noted that regulatory change after market entry was their most influential risk for cross-border operations. Other concerns include border disruption (46%) and unexpected fines (38%). Technology emerges as a source of stability: Businesses are now embedding technology directly into their expansion strategies. 87%3 of respondents now use AI for cross-border operations. More than a quarter (27%) are deploying it broadly and 19% have made it central to their risk management. Rather than waiting for regulatory clarity, companies are engineering their own predictability through data-driven compliance systems and automation. One global challenge, different regional pressures: While uncertainty seems universal, its impact varies by region. In the U.S., concerns about sudden policy shifts are driving higher levels of AI adoption. In the UK, post-Brexit divergence and friction with Europe continue to reshape trade strategies. And in Australia and India, regulatory fragmentation and shifting trade alliances complicate market entry. Across markets, technology is emerging as the common foundation for sustainable growth in today's volatile trading environments. The full 2026 Cross-Border Chaos Report, including regional breakdowns and industry insights, is available to download at: newsroom.avalara.com/image/Avalara+Cross-Border+Chaos+Report.pdf About the Cross-Border Chaos ReportAvalara commissioned Censuswide to survey 1,500 senior business decision‐makers within businesses / retailers that trade and / or sell goods cross-border across the U.S., UK, India and Australia. The data was collected between January 13 – 20, 2026. Censuswide is a member of the Market Research Society (MRS) and the British Polling Council (BPC), and a signatory of the Global Data Quality Pledge. We adhere to the MRS Code of Conduct and ESOMAR principles. About AvalaraAvalara is the agentic tax and compliance leader. For more than two decades, Avalara has developed one of the most expansive libraries of tax content and integrations in the industry, supporting over 200,000 direct and indirect customers across more than 75 countries. The company's purpose-built AI agents automate end-to-end compliance processes with greater precision, from tax calculations and return filings to exemption certificate management and beyond. For more information, visit Avalara.com. 1 'Strongly agree' and 'Somewhat agree' responses combined 2 'Much more complex' and 'Slightly more complex' responses combined 3 Inverse of 'Not using AI for this purpose' Logo - https://mma.prnasia.com/media2/2407832/Avalara_Logo.jpg?p=medium600
2026-02-16 22:00:00

eufy Raises the Bar for Home Cleaning with Omni C28, Delivering One-Pass-Clean Performance with HydroJetTM Self-Clean Roller Mop
Designed for busy homes with kids and pets, delivering deep cleaning with minimal effort KUALA LUMPUR, Malaysia, Feb. 14, 2026 /PRNewswire/ -- eufy, the leading smart home appliances brand by Anker Innovations, today introduces the eufy Robot Vacuum Omni C28, the latest all-in-one cleaning solution designed for busy households, particularly families with pets and children. Powered by its HydroJetTM Self-Clean Roller Mop, the Omni C28 delivers true one-pass clean performance for everyday messes, combining advanced cleaning technology with hands-free convenience to give families more time to focus on what matters most. HydroJetTM Self-Clean Roller Mop – Real-Time Self-cleaning, Real Results Whether it's spilled juice in the kitchen after breakfast, muddy paw prints from a rainy walk, or stubborn sauce stains in the dining area, the Omni C28 ensures every surface is spotless, giving families a clean home without constant supervision. Its signature HydroJetTM Self-Clean Roller Mop is designed to tackle tough messes with ease. With 24 ports spray and 10N of pressure, the mop continuously cleans itself while scrubbing floors, effectively lifting stubborn stains in a single pass. Wastewater is collected automatically into a dedicated tank, keeping your home hygienic with minimal effort. Featuring a 27cm-long roller mop, the Omni C28 covers more floor area with each pass, supporting more efficient cleaning and consistently thorough results. Powerful 15,000Pa Suction for Every Mess From crumbs on the living room floor after movie night, scattered cereal in the kids' playroom, or pet hair along hallway runners, the Omni C28 tackles every mess effortlessly. Boasting 15,000Pa of powerful suction, it captures dust, pet hair, crumbs, and other debris efficiently. Its optimised airflow and brush system maintain consistent suction across hardwood floors, tiles, and carpets, ensuring no corner is left behind. DuoSpiralTM Detangle Brush – Effortless Detangling for Pet and Human Hair Whether it's long-haired dogs lounging in the living room, cats shedding on the carpet, or loose strands of hair left behind after brushing, the Omni C28 keeps fur and hair from tangling around the rollers, even during extended cleaning sessions. Its double-side brush design boosts cleaning efficiency by 5% compared to single-side brushes, ensuring smooth, uninterrupted performance and saving households time and effort. All-in-One Station – Up to 75 Days Hands-Free After weekend baking spills, post-playtime messes, or daily dirt tracked in from outside, families can rely on the Omni C28 to handle it all without constant supervision. Its All-in-One Station minimises maintenance by managing mop cleaning, hot air drying, dust emptying, water tank refills, and automatic wastewater collection. With a four-air-duct system delivering 25% faster drying, the Omni C28 is always ready for the next cleaning cycle, keeping homes spotless with minimal effort. iPathTM 2.0 Laser Navigation – Smart and Smooth Scattered toys in the living room, shoes by the doorway, or delicate plants on shelves won't slow down the Omni C28, which cleans efficiently while leaving the home intact. Equipped with advanced sensors, LiDAR detection, and obstacle avoidance, it navigates around furniture, trash bins, and other common obstacles while adapting to different home layouts. Anti-slip tires allow it to pass doorways up to 20mm, and the intelligent lifting roller keeps carpets dry up to 10.8mm in height. Availability The eufy Robot Vacuum Omni C28 is now available in black at MYR 2299. Customers can purchase the Omni C28 at Shopee, Lazada, and TikTok Shop. The launch of the Omni C28 demonstrates eufy's ongoing commitment to smart, human-first technology, providing households with a cleaning solution that is efficient, reliable, and virtually hands-free so families can enjoy a spotless home without the hassle. About Anker Innovations Anker Innovations is a global leader in charging and home energy storage technology and a developer of unique, consumer electronic products that support premium audio, mobile entertainment and the emerging smart home space. This innovation is being led by its three key brands: Anker, eufy and soundcore. More information on Anker Innovations and its various brands can be found at anker.com. About eufy eufy is a subbrand of Anker Innovation. eufy smart home products and technologies - including home and property security devices and services and smart cleaning solutions - deliver expert protection and deep-cleaning capabilities tailored to your lifestyle. eufy looks beyond functional performance to meet the needs and enrich the lives of the people you care about the most. Care is what makes a house a home, and everything we build is "Built With Care" for you. Find more information at eufy.com.
2026-02-14 02:00:00

WaveSpeedAI Launches "Desktop": The Ultimate Workflow for Power Users Running Daily AI Models
SAN FRANCISCO, Feb. 13, 2026 /PRNewswire/ -- WaveSpeedAI, a leader in multimodal inference acceleration, today announced the launch of WaveSpeedAI Desktop. This professional-grade workspace is designed to transform AI generation from a series of experimental tasks into a streamlined, high-efficiency production workflow. As AI moves into professional production, the bottleneck has shifted from model capability to workflow friction. WaveSpeedAI Desktop solves this by providing a structured local environment built for creators and developers who need to move fast. Key Features for Professional Efficiency: Multi-tab Workspace: Compare results across multiple models and parameters in one unified view. High-Volume Batching: Generate up to 16 variations simultaneously for rapid creative iteration. One-Click Templates: Save complex model and parameter configurations for instant reuse. Full LoRA Support: Complete management for precise style control and personalized generation. Local Asset Management: A robust history system that provides version control and easy traceability for all generated content. "Less Friction, More Creating" "The goal of Desktop is simple: to make the tool disappear so creation can take center stage," said the WaveSpeedAI Team. "We are bridging the gap between high-speed infrastructure and the daily needs of the power user." Availability WaveSpeedAI Desktop is now available for download. For more information, visit: https://wavespeed.ai/landing/desktop About WaveSpeedAI WaveSpeedAI provides the underlying infrastructure for high-speed, secure multimodal generation, empowering the next generation of AI-driven creativity. Media Contact: shu@wavespeed.ai
2026-02-12 16:30:00

Spring Travel in Taiwan: Discover Three Birdwatching Highlights in Yunlin-Chiayi-Tainan -- Your One-Stop Coastal Getaway
Winter Migratory Birdwatching in Yunlin–Chiayi–Tainan × A Slow-City Experience in Tainan × The Taiwan Lantern Festival in Chiayi TAIPEI, Feb. 12, 2026 /PRNewswire/ -- A report from The Hub News: As the spring travel season approaches, the Southwest Coast National Scenic Area Headquarters under Taiwan's Tourism Administration, in partnership with local stakeholders, has introduced a new spring travel program that blends ecological discovery, cultural exploration, and sustainable tourism experiences. Taiwan Lantern Festival In Chiayi (Image source: Taiwan Lantern Festival official website) This curated itinerary brings together coastal birdwatching across the Yunlin–Chiayi–Tainan region, leisurely journeys through Tainan's historic heritage, culinary culture, and vibrant city life, as well as the spectacular 2026 Taiwan Lantern Festival in Chiayi. Together, these experiences create a seamless, one-stop journey designed to showcase the unique natural beauty, cultural richness, and coastal charm of southern Taiwan. Black-faced Spoonbill (Image source: Southwest Coast National Scenic Area Headquarters) Yunlin–Chiayi–Tainan Coast: The Last Chance for Spring Migratory Birdwatching Spring marks the final prime season for observing migratory birds before their northward migration. The Yunlin–Chiayi–Tainan coastal region features lagoons, sandbars, wetlands, and mangrove ecosystems that support hundreds of bird species each winter. Rare birds such as the black-faced spoonbill and pied avocet are active in salt pans and wetlands, and guided local tours allow visitors to observe birdlife easily with the naked eye or a smartphone—an experience suitable for families and international birdwatching enthusiasts alike. Discover Slow Travel in Tainan: Asia's Leading Sustainable Tourism City Recognized in 2023 as one of the world's Top 10 Sustainable Tourism Destinations, Tainan is the only Asian city to receive this distinction. Within its historic alleyways, temple lanterns glow alongside centuries-old residences, while vibrant street food culture blends seamlessly with rich heritage—making Tainan an ideal destination for immersive cultural travel. Visitors can embrace a "slow travel, slow dining, and slow living" experience, exploring Anping, Sicao, and the Qigu Salt Mountain via the Taiwan Tourist Shuttle. This relaxed journey offers an authentic way to experience Tainan's sustainable lifestyle and distinctive cultural charm. Tea Discourse Repository (Image source: Taiwan Lantern Festival official website) 2026 Taiwan Lantern Festival in Chiayi: Where Technology Meets Tradition The 2026 Taiwan Lantern Festival will take place from March 3 to 15 in Taibao City, Chiayi County, under the theme "Illuminate Taiwan, Shine Chiayi." Blending traditional lantern craftsmanship with digital technology, the festival will showcase more than 600 illuminated art installations. The main lantern draws inspiration from the sacred giant trees of Alishan, symbolizing Chiayi's rich cultural heritage and natural landscapes. Beyond the main exhibition area, visitors can explore themed IP zones (including Super Mario), interactive light installations, and family-friendly activities, creating an immersive nighttime experience of light, art, and culture for visitors of all ages. A One-Stop Spring Travel Experience You Won't Want to Miss This integrated three-in-one travel experience highlights the diverse natural landscapes and cultural richness of southern Taiwan while embracing the principles of sustainable tourism. It invites travelers to explore Taiwan in spring at a relaxed pace, encouraging deeper, more meaningful connections with both nature and local culture. Equally appealing is the convenience of the journey: the three destinations are all within easy reach of one another, with travel times of roughly an hour between sites by car or public transport. For international visitors, the region is just over an hour from Kaohsiung International Airport, making this spring getaway both accessible and effortlessly enjoyable. Article source: https://www.thehubnews.net/archives/597105
2026-02-12 16:28:00

e-STORAGE and Sunraycer Announce 503 MWh Battery Energy Storage Projects in Texas
KITCHENER, ON, Feb. 5, 2026 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that e-STORAGE, its energy storage solutions business, and Sunraycer, a leading developer, owner, and operator of clean energy power sites, have entered into agreements for the supply and long-term servicing of two standalone battery energy storage projects totaling 503 MWh DC in Franklin County, Texas. The projects, collectively referred to as the Lupinus projects, are being developed by Sunraycer. They comprise Lupinus 1, a 202 MWh facility expected to begin construction in Q1 2027 and reach commercial operation in Q3 2027, and Lupinus 2, a 301 MWh facility scheduled to start construction in Q3 2026 and achieve commercial operation in Q2 2027. Under the agreements, e-STORAGE will deliver its SolBank 3.0 battery energy storage system and provide 10 years of long-term services, supporting system reliability, performance optimization, and availability throughout the project lifecycle. The battery cells integrated into SolBank 3.0 are manufactured within Canadian Solar's global manufacturing network, reinforcing supply chain resilience and long-term operational reliability at scale. The Lupinus projects will play a vital role in supporting renewable energy integration and enhancing grid stability within the ERCOT market, one of North America's fastest-growing and most dynamic energy storage markets. This collaboration reflects both companies' shared commitment to deploying secure, scalable, and efficient energy storage solutions that enable a more flexible and resilient power grid. David Lillefloren, CEO of Sunraycer, said: "Partnering with e-STORAGE on the Lupinus projects represents a significant step forward in Sunraycer's mission to advance sustainable energy infrastructure across Texas and beyond. These projects both strengthen the reliability of the ERCOT grid and underscore the critical role of battery storage in supporting the clean energy transition. Together with e-STORAGE, we're delivering long-term value to our communities and customers in Texas." Colin Parkin, President of Canadian Solar and President of e-STORAGE, said: "We are pleased to partner with Sunraycer on the Lupinus projects in Texas. Building on our established collaboration, these systems will leverage our BESS technology and service platform to deliver long-term operational value and support the continued growth of reliable, utility-scale energy storage infrastructure across Texas." About Canadian Solar Inc. Canadian Solar is one of the world's largest solar technology and renewable energy companies. Founded in 2001 and headquartered in Kitchener, Ontario, the Company is a leading manufacturer of solar photovoltaic modules; provider of solar energy and battery energy storage solutions; and developer, owner, and operator of utility-scale solar power and battery energy storage projects. Over the past 24 years, Canadian Solar has successfully delivered nearly 170 GW of premium-quality, solar photovoltaic modules to customers across the world. Through its subsidiary e-STORAGE, Canadian Solar has shipped over 16 GWh of battery energy storage solutions to global markets as of September 30, 2025, boasting a $3.1 billion contracted backlog as of October 31, 2025. Since entering the project development business in 2010, Canadian Solar has developed, built, and connected approximately 12 GWp of solar power projects and 6 GWh of battery energy storage projects globally. Its geographically diversified project development pipeline includes 25 GWp of solar and 81 GWh of battery energy storage capacity in various stages of development. Canadian Solar is one of the most bankable companies in the solar and renewable energy industry, having been publicly listed on the NASDAQ since 2006. For additional information about the Company, follow Canadian Solar on LinkedIn or visit www.canadiansolar.com. About e-STORAGE e-STORAGE is a subsidiary of Canadian Solar and a leading company specializing in designing, manufacturing, and integrating battery energy storage systems for utility-scale applications. e-STORAGE offers proprietary battery energy storage solutions, comprehensive EPC services, and innovative solutions aimed at improving grid operations. Currently, e-STORAGE operates fully automated, state-of-the-art manufacturing facilities with an annual battery energy storage system capacity of 15 GWh and battery cell capacity of 3 GWh, on a single-shift and double-shift annualized basis, respectively. For more info, please refer to the Media&PR section of www.csestorage.com and follow our LinkedIn page. About Sunraycer Sunraycer, a Crayhill Capital Management portfolio company, is a rapidly-growing, Annapolis, Maryland-based renewable energy platform that has a development and construction stage pipeline of approximately 2 GW of solar and 2 GW of BESS utility-scale power plants. Sunraycer provides pre-NTP and acquisition capital to developers involved in all types of renewable energy endeavors. Its goal is to streamline the complexities of development and eliminate financing challenges for the developer community. Sunraycer leverages enterprise-scale partnerships with proven industry leaders, as well as an experienced and driven in-house team of renewable energy experts, to accelerate the deployment of development-stage projects. For more information, please visit Sunraycer's website at https://sunraycer.com/ or follow Sunraycer on LinkedIn for the latest company news and events. Safe Harbor/Forward-Looking Statements Certain statements in this press release, including those regarding the Company's expected future shipment volumes, revenues, gross margins, and project sales are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially. These statements are made under the "Safe Harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by such terms as "may", "will", "expect", "anticipate", "future", "ongoing", "continue", "intend", "plan", "potential", "prospect", "guidance", "believe", "estimate", "is/are likely to" or similar expressions, the negative of these terms, or other comparable terminology. These forward-looking statements include, among other things, our expectations regarding global electricity demand and the adoption of solar and battery energy storage technologies; our growth strategies, future business performance, and financial condition; our transition to a long-term owner and operator of clean energy assets and expansion of project pipelines; our ability to monetize project portfolios, manage supply chain fluctuations, and respond to economic factors such as inflation and interest rates; our outlook on government incentives, trade measures, regulatory developments, and geopolitical risks; our expectations for project timelines, costs, and returns; competitive dynamics in solar and storage markets; our ability to execute supply chain, manufacturing, and operational initiatives; access to capital, debt obligations, and covenant compliance; relationships with key suppliers and customers; technological advancement and product quality; and risks related to intellectual property, litigation, and compliance with environmental and sustainability regulations. Other risks were described in the Company's filings with the Securities and Exchange Commission, including its annual report on Form 20-F filed on April 30, 2025. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, level of activity, performance, or achievements. Investors should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today's date, unless otherwise stated, and Canadian Solar undertakes no duty to update such information, except as required under applicable law. Canadian Solar Inc. Investor Relations Contact Wina HuangInvestor RelationsCanadian Solar Inc.investor@canadiansolar.com e-STORAGE MEDIA CONTACTmarketing@csisolar.com Sunraycer Media InquiriesJake ForrestalProsek Partnerspro-crayhill@prosek.com
2026-02-05 14:00:00

COLE HAAN INTRODUCES SPRING 2026 CAMPAIGN: MEET EVERY MOMENT
The new global campaign captures the quiet confidence of modern life where style moves with you. NEW YORK, Feb. 5, 2026 /PRNewswire/ -- Cole Haan, the American lifestyle and accessories brand, today launches its Spring 2026 global campaign: Meet Every Moment. A seasonal expression of the brand's belief that style should feel as effortless as it looks, the campaign showcases a world where people move seamlessly between life's moments. From first dates and weekend matches to walks in the park, Meet Every Moment unfolds through a series of intimate, lifestyle-driven vignettes where confidence reveals itself in how you show up and connect. Cole Haan Meet The Moment Campaign "The Cole Haan Spring 2026 campaign is just the beginning," said Krissie Millan, Chief Marketing Officer. "It's an important step forward, not only in how our product portfolio continues to evolve, but how our brand narrative comes together in a more modern, connected way. Spring sets the tone for what's ahead as we continue to refine how Cole Haan shows up in people's lives and how they feel what's possible through everyday movement." Building on the momentum of recent innovation milestones, the Spring 2026 campaign highlights Cole Haan's heritage of craftsmanship through a forward-looking lens, where innovation is designed not just to perform, but to move seamlessly through real life. In Men's, the 6.ZERØGRANDTM with Quick-OnTM Technology introduces a no-hands-required integrated "shoehorn" and dynamic stretch lacing for effortless on and off, while the RippleFlexTM outsole mirrors the natural anatomy and motion of the foot. Powered by ENERGYFEELTM cushioning, the 360 design delivers flexibility, stability, and responsive comfort with every step, while maintaining a refined, tailored look with sneaker-level performance. In Women's, the ØriginalGrand CitySpectre Oxford has a sculpted, modern outsole also elevated by ENERGYFEELTM cushioning that absorbs impact and delivers rebound, providing polish without compromise. Designed to transition effortlessly across occasions, these styles reinforce Cole Haan's leadership in modern hybrid footwear, redefining how dress shoes feel, move, and perform. "At Cole Haan, comfort through innovation is not an afterthought—it's the foundation of our brand," said Scott Patt, Chief Creative Officer. "Spring 2026 advances that idea even further, with products designed to feel effortless and modern, without ever sacrificing style—from no-hands-needed technology to highly responsive cushioning platforms." Expanding the brand's momentum in sneakers, GrandPrø Tennis 2.0 launched earlier this year, introduces new colorways in March for a Spring refresh. Engineered with FeatherFeelTM cushioning, the brand's lightest cushioning platform to date, the reinvented classic court sneaker delivers soft, springy steps within a streamlined silhouette designed for all-day comfort. Supporting the franchise, the Men's GrandPrø Slimline Sneaker and Women's GrandPrø Energyweave Runner round out the assortment with low-profile silhouettes inspired by classic sport and modern lifestyle dressing. These styles help anchor the Cole Haan Sneaker Club and reflect how sport, style, and everyday life increasingly intersect. As part of the brand's continued expansion in sneakers, Cole Haan Sneaker Club is a platform showcasing the brand's range of premium lifestyle and performance sneakers: supremely comfortable, thoughtfully crafted, and inspired by the heritage and iconography of sport, reimagined for the future. The Meet Every Moment campaign is developed in partnership with Invisible Dynamics, a brand transformation agency, and will roll out globally throughout the Spring season across digital, social, retail, and in-store experiences. Cole Haan's Spring 2026 collection is now available at colehaan.com and in select stores worldwide beginning February 2026, with new products introduced throughout the season. ABOUT COLE HAAN Cole Haan is a global American lifestyle brand available in more than 100 countries, serving always-connected, active professionals with innovative footwear and lifestyle accessories. With a nearly 100-year heritage, Cole Haan infuses its products with time-honored craftsmanship and modern innovation—creating styles designed for work, workout, and weekend. The brand's mission is to inspire customers to live extraordinary lives. To learn more, visit colehaan.com. Follow along @colehaan. Press Contact:Press@colehaan.com Jennifer Bett Communications colehaan@jbc-pr.com Men’s 6.ZERØGRAND Laser Quick-OnTM Oxfords Women’s CitySpectre Oxfords Women’s Alexandria Collection Men’s 6.ZERØGRAND Laser Quick-OnTM Oxfords
2026-02-05 14:00:00

США продали первую партию венесуэльской нефти за $500 млн
Вашингтонская администрация завершила выплату властям Венесуэлы $500 млн, полученных в результате продажи партии нефти из боливарианской республики.Как передает Vesti.az со ссылкой на ТАСС, об этом сообщило во вторник агентство Reuters, ссылаясь на должностное лицо США."Венесуэла официально получила все $500 млн от первой продажи венесуэльской нефти", - отметил чиновник. Он заверил, что средства должны быть "распределены в интересах венесуэльского народа по усмотрению правительства США". Какой именно объем нефти был продан, не уточняется.Чиновник добавил, что Вашингтон намерен в будущем переводить средства от продажи венесуэльской нефти в фонд в США. Далее их будут с разрешения американской стороны передавать властям республики.Уполномоченный президент боливарианской республики Делси Родригес в конце января заявила, что Венесуэла получила "первые $300 млн из $500 млн" от продажи нефти. Как следует из публикации агентства, США теперь выплатили оставшиеся $200 млн.Американский президент Дональд Трамп 9 января заявил, что власти Венесуэлы согласились передать США 30 млн баррелей нефти. Он тогда отметил, что эта партия энергоносителя стоит $4 млрд. 6 января Трамп сообщил, что власти республики согласились передать США от 30 млн до 50 млн баррелей нефти для продажи, а контролировать доходы от этой транзакции будет он. Трамп подчеркивал, что Венесуэла будет закупать только продукцию США на средства, которые республика выручит от этой сделки по продаже своей нефти.
2026-02-04 04:08:51

Azərbaycanın sülh diplomatiyası
Bu, beynəlxalq ictimaiyyət tərəfindən nümunə kimi dəyərləndirilir "Bu gün Cənubi Qafqaz yeni inkişaf mərhələsinə daxil olur. Biz beş-altı aydır sülh şəraitində yaşayırıq. Buna öyrəşirik. Öz müstəqillik tariximizdə heç zaman sülh şəraitində yaşamamışıq. Xüsusi hissdir və əlbəttə ki, böyük fürsətdir. Bu gün Azərbaycan ilə Ermənistan arasında münasibətlər artıq əməkdaşlığa çevrilir. ...Düşünürəm ki, Ermənistan və Azərbaycanın, eləcə də vətəndaş cəmiyyətinin birgə səyləri ilə biz Qafqazda uzunmüddətli deyil, əbədi sülhə nail olacağıq. Məqsədimiz budur". Yanvarın 20-də Davosda "Euronews" televiziyasına müsahibəsi zamanı Prezident İlham Əliyevin bəyan etdiyi kimi, Azərbaycan düşünülmüş və çevik siyasət həyata keçirməklə, eləcə də strateji yanaşma ortaya qoymaqla Cənubi Qafqazda yeni reallıqlar formalaşdırıb. Bu siyasət bölgədə uzun illər hökm sürən qarşıdurma mühitini aradan qaldıraraq sabitlik, təhlükəsizlik və əməkdaşlıq üçün mühüm imkanlar yaradıb. Bu isə onu deməyə əsas verir ki, Azərbaycan üçün hər zaman prioritet hədəf dayanıqlı sülhün bərqərar edilməsi olub və postmünaqişə dövründə normallaşma istiqamətində atdığı praqmatik addımlarla regionu inkişaf, əməkdaşlıq yoluna çıxarıb. Məhz bu siyasi iradə sayəsində Azərbaycan hazırda yalnız regional proseslərin iştirakçısı deyil, eyni zamanda həmin proseslərin formalaşdırıcısı və istiqamətini müəyyən edən əsas aktorlardan biri kimi çıxış edir. Mükəmməl nümunəPrezident İlham Əliyevin Birləşmiş Ərəb Əmirliklərinin nüfuzlu Şeyx Zayed Fondu tərəfindən "Zayed İnsan Qardaşlığı Mükafatı"na layiq görülməsi də elə həyata keçirilən sülh siyasətinin beynəlxalq miqyasda yüksək qiymətləndirilməsinin bariz göstəricisidir. Sözügedən mükafat Qafqazda onilliklər ərzində davam edən münaqişəyə və humanitar əzablara son qoyan - "Azərbaycan Respublikası və Ermənistan Respublikası arasında sülhün və dövlətlərarası münasibətlərin təsis edilməsi haqqında Saziş"in paraflanmasına görə verilib. Bu fakt bir daha sübut edir ki, Prezident İlham Əliyevin qətiyyətli siyasi iradəsi və prinsipial mövqeyi bölgədə de-fakto sülhün təmin olunmasında həlledici rol oynayıb. Prezident İlham Əliyev yanvarın 9-da Müsəlman Ağsaqqalları Şurasının baş katibi Məhəmməd Əbdülsalamı, "Zayed İnsan Qardaşlığı Mükafatı"nın münsiflər heyətinin üzvləri - Avropa İttifaqı Şurasının sabiq prezidenti Şarl Mişeli və Afrika İttifaqı Komissiyasının sabiq sədri Musa Fakini qəbul edib. Həmin zaman adıçəkilən mükafatın münsiflər heyətinin üzvlərinin ötən il dünya üzrə bütün sülh modellərinin araşdırılmasından sonra Azərbaycan ilə Ermənistan arasında sülh müqaviləsinin modelinin münaqişə və müharibə olan digər bölgələrdə də tətbiqi üçün gözəl nümunə olması barədə qərar qəbul etdikləri bildirilib."Münsiflər heyətinin adından demək istərdim ki, sülh sazişi üzrə uğurun əldə olunması üçün Zati-alinizin gördüyü işlər bizim hamımızı ruhlandırır və dünyanın müxtəlif yerlərində mövcud münaqişə bölgələri üçün sülhün möhtəşəm bir nümunəsidir.Biz və bütün dünya bunu dəyərlər baxımından yüksək qiymətləndiririk, çünki dünyanın, həqiqətən, buna ehtiyacı var. Həmin mükafatın Sizə təqdim edilməsi sazişin sülh, barışıq və regional sabitliyin bərqərar edilməsi baxımından əhəmiyyətini göstərir. Cənab Prezident, Sizə həqiqətən təşəkkürümüzü bildiririk", - deyə, Müsəlman Ağsaqqalları Şurasının baş katibi Məhəmməd Əbdülsalam Azərbaycan Prezidentinin sülh səylərinə beynəlxalq səviyyədə yüksək dəyər verildiyini bu sözləri ilə dilə gətirdi.Qlobal çağırışlara töhfəBütün bu nümunələr ortaya qoyur ki, qlobal miqyasda sülhün və sabitliyin ciddi sınaqdan keçdiyi bir dövrdə Azərbaycanın ortaya qoyduğu sülh modeli həm region ölkələri, həm də beynəlxalq ictimaiyyət üçün nümunə kimi dəyərləndirilir. Eyni zamanda bu mükafat Azərbaycan Prezidentinin yalnız region daxilində deyil, qlobal səviyyədə də sülhə, dialoqa və qarşılıqlı anlaşmaya verdiyi töhfələrin rəsmi təsdiqi kimi ön plana çıxır. Bu faktdır ki, Azərbaycan təkcə regional müstəvidə deyil, dünyada barışın əldə olunması üçün hər zaman mühüm təşəbbüslərlə çıxış edir, qlobal çağırışlara töhfələr verir, münaqişələrin, qarşıdurmaların aradan qaldırılması üçün çalışır. Prezident İlham Əliyevin dünyada sülh yaradan lider kimi tanınması dəfələrlə müharibənin astanasına gələn ölkələr arasında vasitəçilik etməklə tarixi barışdırıcılıq missiyası həyata keçirməsi, yəni fəaliyyəti ilə sülhə xidmət etməsi ilə də birbaşa əlaqədardır.Bu mənada "Zayed İnsan Qardaşlığı Mükafatı" Azərbaycanın sülh modelinə və dövlətimizin dünyada barışın bərqərar olması üçün göstərdiyi səylərə beynəlxalq etimadın ifadəsidir. Prezident İlham Əliyevin bu nüfuzlu mükafata layiq görülməsi Azərbaycanın regional sabitliyin təmin olunmasında aparıcı və etibarlı aktor statusunu daha da möhkəmləndirir.Prezident İlham Əliyev beynəlxalq səviyyədə göstərilən yüksək etimadın təzahürü olan bu nüfuzlu mükafatı almağın özü üçün böyük şərəf olduğunu deyib: "Belə nüfuzlu mükafatı almaq mənim üçün böyük şərəfdir. Xüsusən də o, Birləşmiş Ərəb Əmirliklərinin qurucusu, mərhum Şeyx Zayedin adını daşıyır. Mən bu qərarı otuz ildən artıq müddətdə qan tökülməsindən, münaqişə və müharibələrdən sonra Qafqazda sülhün qurulmasında səylərimizə verilən qiymət kimi qəbul edirəm".Bir sözlə, ölkəmizin rəhbərinin "Zayed İnsan Qardaşlığı Mükafatı"na layiq görülməsi Azərbaycanın sülhə, dialoqa və beynəlxalq əməkdaşlığa əsaslanan dövlət siyasətinə verilən yüksək qiymətdir. Bu mükafat ölkəmizin regionda qarşıdurmaların deyil, barışın təşviqçisi kimi çıxış etdiyini, sabitliyin və təhlükəsizliyin təmin olunmasında etibarlı tərəfdaş və uğurlu vasitəçi rolu oynadığını göstərir. Bəli, qlobal sülhün ciddi sınaqlardan keçdiyi bir dövrdə Azərbaycanın nümayiş etdirdiyi məsuliyyətli və düzgün siyasət sayəsində əldə etdiyi sülh uğuru bu gün dünya üçün örnək təşkil edir. Bu onu göstərir ki, davamlı sülh yalnız güclü siyasi iradə, prinsipial mövqe və qarşılıqlı etimada əsaslanan siyasət nəticəsində mümkündür. Məhz bu yanaşma Azərbaycanı regionda sabitliyi bərqərar edən gücə çevirir və ölkəmizin beynəlxalq nüfuzunu daha da möhkəmləndirir.Yasəmən MUSAYEVA, "Azərbaycan"
2026-02-04 04:02:46

AI Innovation to Reshape Asia's Legal Sector - Talent, Governance, Technology
Legal Innovation Festival SE Asia 2026 to Address Challenges, Opportunities SINGAPORE, Feb. 4, 2026 /PRNewswire/ -- Artificial intelligence is having a growing impact on the Singapore legal profession. Insights from the recently released Legal Innovation Asia 2026: AI Meets Law – The Next Frontier report, developed with the Asia-Pacific Legal Innovation & Technology Association (ALITA), show that while generative AI is already changing how legal work is performed, many firms and in-house teams remain uncertain about how to deploy it responsibly, train their people, and align leadership around long-term AI strategy. Against this backdrop, the Legal Innovation Festival Southeast Asia 2026 will take place on 12–13 March 2026 at the Sands Expo & Convention Centre, bringing together law firms, in-house legal teams, regulators, and technology leaders to explore how AI is transforming the practice, delivery, and governance of legal services across Asia. With generative AI adoption accelerating across the industry, the festival comes at a pivotal moment. This momentum is reflected in the report with nearly 90% of respondents across Asia Pacific already using AI in their work, and 51% use both general-purpose and legal specialist AI tools. Findings from the Legal Innovation Asia 2026 report are based on facilitated roundtable discussions with legal professionals across Singapore, Hong Kong and Kuala Lumpur and further reveal that while optimism around AI's potential is high, significant barriers remain. Drawing on these roundtables, the report examines how generative AI is reshaping legal roles and workflows, not replacing lawyers, but changing how legal work is delivered and governed. Key challenges include leadership buy-in, data governance and confidentiality concerns, uneven adoption across jurisdictions, tool selection complexity and the readiness of legal talent to integrate AI meaningfully into day-to-day legal work. Singapore is rapidly emerging as a regional hub for legal tech and AI governance, supported by initiatives such as MinLaw's proposed Guide for Using Generative AI in the Legal Sector, the LIFT pilot, and the Productivity Solutions Grant for the Legal Sector (PSG–Legal). As legal teams across Southeast Asia look to implement AI responsibly, the festival will provide a central meeting point for cross-border collaboration, standard-setting, and knowledge-sharing. Speaking on the festival's regional significance, Anna Turner, Portfolio and Content Director, Hannover Fairs Australia, said, "Legal teams across Asia are seeking clarity, confidence, and practical frameworks for AI adoption. This event brings together the voices that matter most, of practitioners, technologists, regulators, and industry leaders to discuss what responsible AI integration truly looks like. Singapore, with its strong governance, innovation culture and position as a legal hub, is the ideal host for these conversations." Discussing the festival's role in shaping responsible AI adoption across the legal sector, Anastasia Chen, Director and Deputy Head of the Data Protection, Privacy & Cybersecurity practice at Drew & Napier, said, "Over the next few years, legal teams will need to make far more deliberate decisions about where AI can genuinely enhance legal work, and where human oversight must remain central. The challenge is not just adopting technology but doing so in a way that aligns with governance, regulatory expectations, and organisational priorities. Forums like the Legal Innovation Festival are important because they create space for practitioners, in-house teams and technologists to have practical, forward-looking conversations about how AI should be used; responsibly, securely, and with a clear understanding of risk." Across two days, the festival will feature keynote sessions, panel discussions, case studies, product showcases, and networking opportunities designed to equip legal professionals with practical insights on implementing AI and digital tools in their organisations. The 2026 edition will feature leading voices from Singapore and the region, including Laurence Liew, Director of AI Innovation at AI Singapore; Carol Seah, General Counsel at NCS Group; Gladys Chun, General Counsel at Doctors Anywhere; and Mel Nirmala, ASEAN Legal Ops Excellence Lead at Bayer South-East Asia and Head of the CLOC Singapore Chapter. Additional heavyweight speakers from Singapore's public and private legal sectors will also join the programme, reflecting the city-state's growing leadership in legal tech, governance, and AI adoption. The two-day programme will explore the most urgent themes shaping the future of legal work. Discussions will cover the evolving landscape of AI governance, how legal teams can build AI-ready capabilities, and the ethical and practical considerations of deploying generative AI in legal workflows. Attendees will also hear real-world case studies from law firms and in-house teams, examine emerging tools transforming daily legal operations, and engage in conversations on aligning cross-border standards across Asia's legal markets. Early-bird tickets for the Legal Innovation Festival Southeast Asia 2026 are now available, offering discounted rates for registrations made before 27th February 2026. Sponsorship and exhibition opportunities are also open for legal technology companies, service providers and innovation partners looking to showcase solutions, gain visibility, or participate in speaking sessions and product demonstrations. The festival's exhibition floor and curated networking programmes offer direct access to legal decision-makers from across the region. For more information, ticketing details, sponsorship enquiries and the full agenda, please visit https://www.legalinnovationsea.com. About Legal Innovation Festival Southeast Asia 2026 The Legal Innovation Festival SE Asia 2026 is a premier platform to explore the latest ideas and solutions transforming the legal industry. Technology is both disrupting and enabling the practice of law, and as systems evolve, new platforms emerge, and strategies shift, legal professionals must continuously adapt. This event will give legal and allied legal professionals the opportunity to connect and share their knowledge and strategies on how they are navigating these changes. Singapore, with its strong position as a regional legal and innovation hub, is the ideal place to drive this conversation forward, bringing together industry leaders, technologists, and legal professionals from across Southeast Asia to navigate the future of law.
2026-02-04 04:00:00

0.10671305656433


ዜና
ዜና
ኣዘርባጃን።
እዋናዊ ዜናን ኣርእስታትን
ኣዘርባጃን።
ዜና